Ching-Wei D. Tzeng, M.D., FACS

Peer-Reviewed Articles

1. Balachandran Pillai A, Yousef M, Yousef A, Alfaro-Munoz KD, Smaglo BG, Willis J, Wolff RA, Pant S, Hurd MW, Maitra A, Wang H, Katz MHG, Prakash LR, Tzeng CD, Snyder R, Castelnovo LF, Chen A, Kravets A, Kudriavtseva K, Tarasov A, Kryukov K, Ying H, Shen JP, Zhao D. Molecular and Clinical Features of Pancreatic Acinar Cell Carcinoma: A Single-Institution Case Series. Cancers (Basel) 16(19):None, 2024. PMID: 39410042.
2. Taherian M, Katz MHG, Prakash LR, Wei D, Tong YT, Lai Z, Chatterjee D, Wang H, Kim M, Tzeng CD, Ikoma N, Wolff RA, Zhao D, Koay EJ, Maitra A, Wang H. The Association between Sampling and Survival in Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and Pancreaticoduodenectomy. Cancers (Basel) 16(19):None, 2024. PMID: 39409932.
3. De B, Dogra P, Zaid M, Elganainy D, Sun K, Amer AM, Wang C, Rooney MK, Chang E, Kang HC, Wang Z, Bhosale P, Odisio BC, Newhook TE, Tzeng CD, Cao HST, Chun YS, Vauthey JN, Lee SS, Kaseb A, Raghav K, Javle M, Minsky BD, Noticewala SS, Holliday EB, Smith GL, Koong AC, Das P, Cristini V, Ludmir EB, Koay EJ. Measurable imaging-based changes in enhancement of intrahepatic cholangiocarcinoma after radiotherapy reflect physical mechanisms of response. medRxiv None(None):None, 2024. PMID: 39314943.
4. Lu PW, Lyu HG, Prakash LR, Chiang YS, Maxwell JE, Snyder RA, Kim MP, Tzeng CD, Katz MHG, Ikoma N. Effect of surgical approach on early return to intended oncologic therapy after resection for pancreatic ductal adenocarcinoma. Surg Endosc 38(9):4986-4995, 2024. e-Pub 2024. PMID: 38987482.
5. Yousef M, Hurd MW, Yousef A, Ludmir EB, Pillai AB, Peterson J, Koay EJ, Albarouki S, Tzeng CW, Snyder R, Katz MHG, Wang H, Overman MJ, Maitra A, Pant S, Smaglo BG, Wolff RA, Yao J, Shen JP, Zhao D. Clinical and molecular characteristics of patients with brain metastasis secondary to pancreatic ductal adenocarcinoma. Oncologist. e-Pub 2024. PMID: 39014543.
6. Cass SH, Williams LA, Rajaram R, Hirata Y, Rice D, Tzeng CD, Katz MHG, Badgwell BD, Wang XS, Ikoma N. Patient-reported outcome measures in surgical patients with upper gastrointestinal cancers: A qualitative interview study. J Surg Oncol 130(1):117-124, 2024. e-Pub 2024. PMID: 38798277.
7. Maki H, Nishioka Y, Haddad A, Lendoire M, Tran Cao HS, Chun YS, Tzeng CD, Vauthey JN, Newhook TE. Reproducibility and efficiency of liver volumetry using manual method and liver analysis software. HPB (Oxford) 26(7):911-918, 2024. e-Pub 2024. PMID: 38632032.
8. Martin AN, Newhook TE, Arvide EM, Kim BJ, Dewhurst WL, Kawaguchi Y, Tran Cao HS, Chun YS, Katz MH, Vauthey JN, Tzeng CD. Utilizing risk-stratified pathways to personalize post-hepatectomy discharge planning: A contemporary analysis of 1,354 patients. Am J Surg 233:17-23, 2024. e-Pub 2023. PMID: 38129274.
9. Lendoire M, Maki H, Haddad A, Newhook TE, Tzeng CD, Vauthey JN, Tran Cao HS. Exceptional pathologic response to preoperative therapy in the context of mutational profiling for colorectal liver metastases. J Gastrointest Surg 28(7):1181-1184, 2024. e-Pub 2024. PMID: 38723997.
10. Tran Cao HS, Witt RG, Elsayes KM, Baiomy AA, Xiao L, Palmquist S, Lee SS, Mohamed YI, Mahvash A, Tzeng CD, Chun YS, Koay EJ, Rashid A, Hassan MM, Yao JC, Vauthey JN, Kaseb AO. Development of a Novel Comprehensive Hepatocellular Carcinoma Outcome Prognostic Scoring System With Integration of Imaging Features. Oncologist 29(6):e803-e810, 2024. e-Pub 2023. PMID: 38159256.
11. Boyev A, Azimuddin A, Prakash LR, Newhook TE, Maxwell JE, Bruno ML, Arvide EM, Dewhurst WL, Kim MP, Ikoma N, Lee JE, Snyder RA, Katz MHG, Tzeng CD. Classification of Post-Pancreatectomy Readmissions and Opportunities for Targeted Mitigation Strategies. Ann Surg 279(6):1046-1053, 2024. e-Pub 2023. PMID: 37791481.
12. Shi C, De B, Tran Cao HS, Liu S, Florez MA, Kouzy R, Grippin AJ, Katz MHG, Tzeng CD, Ikoma N, Kim MP, Lee S, Willis J, Noticewala SS, Minsky BD, Smith GL, Holliday EB, Taniguchi CM, Koong AC, Das P, Ludmir EB, Koay EJ. Escalated-dose radiotherapy for unresected locally advanced pancreatic cancer: Patterns of care and survival in the United States. Cancer Med 13(12):e7434, 2024. PMID: 38923407.
13. Boyev A, Popat K, Gottumukkala VNR, Kwater AP, Chiang YJ, Prakash LR, Newhook TE, Arvide EM, Dewhurst WL, Bruno ML, Van Meter A, Hancher-Hodges S, Ghebremichael S, Williams U, Donahue H, Soliz J, Tzeng CD. Postoperative pain scores and opioid use after standard bupivacaine vs. liposomal bupivacaine regional blocks for abdominal cancer surgery: A propensity score matched study. Am J Surg. e-Pub 2024. PMID: 38789322.
14. Chang E, MD, Wong FC, MD, PhD, JD, Chasen BA, MD, Erwin WD, MS, Das P, MD, MS, MPH, Holliday EB, MD, Koong AC, MD, PhD, Ludmir EB, MD, Minsky BD, MD, Noticewala SS, MD, MAS, Smith GL, MD, PhD, MPH, Taniguchi CM, MD, PhD, Rodriguez MJ, MBA, RN, Beddar S, PhD, Martin-Paulpeter RM, PhD, Niedzielski JS, PhD, Sawakuchi GO, PhD, Schueler E, PhD, Perles LA, PhD, Xiao L, MS, Szklaruk J, MD, PhD, Park PC, PhD, Dasari AN, MD, MS, Kaseb AO, MD, Kee BK, MD, Lee SS, MD, PhD, Overman MJ, MD, Willis JA, MD, PhD, Wolff RA, MD, Tzeng CD, MD, Vauthey J, MD, Koay EJ, MD, PhD. Phase I Trial of SPECT-Guided Liver-Directed Radiotherapy for Patients with Low Functional Liver Volume. JNCI Cancer Spectrum, 2024. PMID: None.
15. Jain AJ, Lendoire M, Boyev A, Newhook TE, Tzeng CD, Tran Cao HS, Coronel E, Lee SS, Hu ZI, Javle M, Lee JH, Vauthey JN, Chun YS. Revisiting the Malignant Masquerade at the Liver Hilum: Have We Made Progress?. Ann Surg Oncol 31(5):3062-3068, 2024. e-Pub 2024. PMID: 38282027.
16. Chang E, Wong FCL, Chasen BA, Erwin WD, Das P, Holliday EB, Koong AC, Ludmir EB, Minsky BD, Noticewala SS, Smith GL, Taniguchi CM, Rodriguez MJ, Beddar S, Martin-Paulpeter RM, Niedzielski JS, Sawakuchi GO, Schueler E, Perles LA, Xiao L, Szklaruk J, Park PC, Dasari AN, Kaseb AO, Kee BK, Lee SS, Overman MJ, Willis JA, Wolff RA, Tzeng CD, Vauthey JN, Koay EJ. Phase I trial of single-photon emission computed tomography-guided liver-directed radiotherapy for patients with low functional liver volume. JNCI Cancer Spectr 8(3), 2024. PMID: 38730548.
17. Dekker EN, van Dam JL, Janssen QP, Besselink MG, DeSilva A, Doppenberg D, van Eijck CHJ, Nasar N, O'Reilly EM, Paniccia A, Prakash LR, Tzeng CD, Verkolf EMM, Wei AC, Zureikat AH, Katz MHG, Groot Koerkamp B, Surgery Consortium TP. Improved Clinical Staging System for Localized Pancreatic Cancer Using the ABC Factors: A TAPS Consortium Study. J Clin Oncol 42(12):JCO2301311, 2024. e-Pub 2024. PMID: 38315954.
18. Boyev A, Arvide EM, Newhook TE, Prakash LR, Bruno ML, Dewhurst WL, Kim MP, Maxwell JE, Ikoma N, Snyder RA, Lee JE, Katz MHG, Tzeng CD. Prophylactic Antibiotic Duration and Infectious Complications in Pancreatoduodenectomy Patients with Biliary Stents: Opportunity for De-Escalation. Ann Surg 279(4):657-664, 2024. e-Pub 2023. PMID: 37389897.
19. Azimuddin A, Tzeng CD, Prakash LR, Bruno ML, Arvide EM, Dewhurst WL, Newhook TE, Kim MP, Ikoma N, Snyder RA, Lee JE, Perrier ND, Katz MH, Maxwell JE. Postoperative Global Period Cost Reduction Using 3 Successive Risk-Stratified Pancreatectomy Clinical Pathways. J Am Coll Surg 238(4):451-459, 2024. e-Pub 2024. PMID: 38180055.
20. Boyev A, Tzeng CD, Maki H, Arvide EM, Mrema DE, Jain AJ, Haddad A, Lendoire M, Malik N, Odisio BC, Chun YS, Tran Cao HS, Vauthey JN, Newhook TE. Local Therapy Improves Survival for Early Recurrence After Resection of Colorectal Liver Metastases. Ann Surg Oncol 31(4):2547-2556, 2024. e-Pub 2023. PMID: 38148351.
21. Theijse RT, Stoop TF, Janssen QP, Prakash LR, Katz MHG, Doppenberg D, Tzeng CD, Wei AC, Zureikat AH, Groot Koerkamp B, Besselink MG. Impact of a non-therapeutic laparotomy in patients with locally advanced pancreatic cancer treated with induction (m)FOLFIRINOX: Trans-Atlantic Pancreatic Surgery (TAPS) Consortium study. Br J Surg 111(3), 2024. PMID: 38456678.
22. Stoop TF, Doppenberg D, Katz MHG, Tzeng CD, Wei AC, Zureikat AH, Groot Koerkamp B, Besselink MG, Surgery Consortium TP. ASO Author Reflections: The Value of Serum CEA for Prognostication at Staging and Response Evaluation in Patients with Localized Pancreatic Adenocarcinoma and Nonelevated CA19-9. Ann Surg Oncol 31(3):1842-1843, 2024. e-Pub 2024. PMID: 38182848.
23. Jain AJ, Newhook TE, Lilley E, Ikoma N, Tzeng CD, Chun YS, Vauthey JN, Tran Cao HS. A Practical Guide to Inflow Control, Retraction, and Exposure for Robotic Hepatectomy. Ann Surg Oncol 31(3):1833, 2024. e-Pub 2023. PMID: 37989954.
24. Albuquerque J, Lin YM, Paolucci I, O'Connor CS, Tzeng CW, Vauthey JN, Brock KK, Odisio BC. Incidental Ring-hyperenhancing Liver Micronodules at CT Hepatic Arteriography-guided Percutaneous Thermal Ablation of Colorectal Liver Metastases. Radiol Imaging Cancer 6(2):e230099, 2024. PMID: 38363196.
25. Doppenberg D, Stoop TF, van Dieren S, Katz MHG, Janssen QP, Nasar N, Prakash LR, Theijse RT, Tzeng CD, Wei AC, Zureikat AH, Groot Koerkamp B, Besselink MG, Surgery Consortium TP. Serum CEA as a Prognostic Marker for Overall Survival in Patients with Localized Pancreatic Adenocarcinoma and Non-Elevated CA19-9 Levels Treated with FOLFIRINOX as Initial Treatment: A TAPS Consortium Study. Ann Surg Oncol 31(3):1919-1932, 2024. e-Pub 2024. PMID: 38170408.
26. Amaria R, Knisely A, Vining D, Kopetz S, Overman MJ, Javle M, Antonoff MB, Tzeng CD, Wolff RA, Pant S, Lito K, Rangel K, Fellman B, Yuan Y, Lu KH, Sakellariou-Thompson D, Haymaker CL, Forget MA, Hwu P, Bernatchez C, Jazaeri AA. Efficacy and safety of autologous tumor-infiltrating lymphocytes in recurrent or refractory ovarian cancer, colorectal cancer, and pancreatic ductal adenocarcinoma. J Immunother Cancer 12(2), 2024. e-Pub 2024. PMID: 38309721.
27. Jain AJ, Lendoire M, Boyev A, Newhook TE, Tzeng CD, Tran Cao HS, Coronel E, Lee SS, Hu Z, Javle M, Lee JH, Vauthey J, Chun YS. ASO Visual Abstract: Revisiting the Malignant Masquerade at the Liver Hilum-Have We Made Progress?. None, 2024. PMID: None.
28. Boyev A, Tzeng CD, Maki H, Arvide EM, Mrema DE, Jain AJ, Haddad A, Lendoire M, Malik N, Odisio BC, Chun YS, Tran Cao HS, Vauthey JN, Newhook TE. ASO Visual Abstract: Local Therapy Improves Survival for Early Recurrence After Resection of Colorectal Liver Metastases. Ann Surg Oncol. e-Pub 2024. PMID: 38252264.
29. Hirata Y, Gottumukkala V, Ajith J, Schmeisser JA, Ninan EP, Maxwell JE, Snyder RA, Kim MP, Tran Cao HS, Tzeng CD, Badgwell BD, Katz MHG, Ikoma N. Laparoscopic transverse abdominis plane block: how I do it and a cost efficiency analysis. Langenbecks Arch Surg 409(1):16, 2023. e-Pub 2023. PMID: 38147123.
30. Boyev A, Azimuddin A, Newhook TE, Maxwell JE, Prakash LR, Bruno ML, Arvide EM, Dewhurst WL, Kim MP, Ikoma N, Snyder RA, Lee JE, Katz MHG, Tzeng CD. Evaluation and Recalibration of Risk-Stratified Pancreatoduodenectomy Drain Fluid Amylase Removal Criteria. J Gastrointest Surg 27(12):2806-2814, 2023. e-Pub 2023. PMID: 37935998.
31. Taniguchi CM, Frakes JM, Aguilera TA, Palta M, Czito B, Bhutani MS, Colbert LE, Abi Jaoude J, Bernard V, Pant S, Tzeng CD, Kim DW, Malafa M, Costello J, Mathew G, Rebueno N, Koay EJ, Das P, Ludmir EB, Katz MHG, Wolff RA, Beddar S, Sawakuchi GO, Moningi S, Slack Tidwell RS, Yuan Y, Thall PF, Beardsley RA, Holmlund J, Herman JM, Hoffe SE. Stereotactic body radiotherapy with or without selective dismutase mimetic in pancreatic adenocarcinoma: an adaptive, randomised, double-blind, placebo-controlled, phase 1b/2 trial. Lancet Oncol 24(12):1387-1398, 2023. PMID: 38039992.
32. Fields BC, Boyev A, Tzeng CD. Response to LTE on Prophylactic Antibiotic Duration. Ann Surg Open 4(4):e345, 2023. e-Pub 2023. PMID: 38144503.
33. Boyev A, Prakash LR, Chiang YJ, Newhook TE, Bruno ML, Arvide EM, Dewhurst WL, Kim MP, Ikoma N, Lee JE, Snyder RA, Tzeng CD, Katz MHG, Maxwell JE. Elevated CA 19-9 is associated with worse survival in patients with resected ampullary adenocarcinoma. Surg Oncol 51:101994, 2023. e-Pub 2023. PMID: 37742542.
34. Swords DS, Newhook TE, Tzeng CD, Massarweh NN, Chun YS, Lee S, Kaseb AO, Ghobrial M, Vauthey JN, Tran Cao HS. ASO Visual Abstract: Treatment Disparities Partially Mediate Socioeconomic- and Race/Ethnicity-Based Survival Disparities in Stage I-II Hepatocellular Carcinoma. Ann Surg Oncol 30(13):8019-8020, 2023. e-Pub 2023. PMID: 37782416.
35. Boyev A, Jain AJ, Newhook TE, Prakash LR, Chiang YJ, Bruno ML, Arvide EM, Dewhurst WL, Kim MP, Maxwell JE, Ikoma N, Snyder RA, Lee JE, Katz MHG, Tzeng CD. Opioid-free discharge after pancreatic resection through a learning health system paradigm. JAMA Surg 158(11):e234154, 2023. e-Pub 2023. PMID: 37672236.
36. Maki H, Kim BJ, Kawaguchi Y, Fernandez-Placencia R, Haddad A, Panettieri E, Newhook TE, Baumann DP, Santos D, Tran Cao HS, Chun YS, Tzeng CD, Vauthey JN, Vreeland TJ. Incidence of and Risk Factors for Incisional Hernia After Hepatectomy for Colorectal Liver Metastases. J Gastrointest Surg 27(11):2388-2395, 2023. e-Pub 2023. PMID: 37537494.
37. Swords DS, Newhook TE, Tzeng CD, Massarweh NN, Chun YS, Lee S, Kaseb AO, Ghobrial M, Vauthey JN, Tran Cao HS. Treatment Disparities Partially Mediate Socioeconomic- and Race/Ethnicity-Based Survival Disparities in Stage I-II Hepatocellular Carcinoma. Ann Surg Oncol 30(12):7309-7318, 2023. e-Pub 2023. PMID: 37679537.
38. Maki H, Ayabe RI, Nishioka Y, Konishi T, Newhook TE, Tran Cao HS, Chun YS, Tzeng CD, You YN, Vauthey JN. Correction: Hepatectomy Before Primary Tumor Resection as Preferred Approach for Synchronous Liver Metastases from Rectal Cancer. Ann Surg Oncol 30(9):5405, 2023. PMID: 37344750.
39. Maki H, Ayabe RI, Nishioka Y, Konishi T, Newhook TE, Tran Cao HS, Chun YS, Tzeng CD, You YN, Vauthey JN. ASO Visual Abstract: Hepatectomy Before Primary Tumor Resection as the Preferred Approach for Synchronous Liver Metastases from Rectal Cancer. Ann Surg Oncol 30(9):5403-5404, 2023. PMID: 37358681.
40. Maki H, Ayabe RI, Nishioka Y, Konishi T, Newhook TE, Tran Cao HS, Chun YS, Tzeng CD, You YN, Vauthey JN. Hepatectomy before primary tumor resection as preferred approach for synchronous liver metastases from rectal cancer. Ann Surg Oncol 30(9):5390-5400, 2023. e-Pub 2023. PMID: 37285096.
41. Spitzer HV, Bohan PMK, Carpenter EL, Adams AM, Chang SC, Grunkemeier G, Vreeland TJ, Tzeng CD, Katz MH, Nelson DW. ASO Visual Abstract: Impact of Adherence to Operative Standards and Stage-Specific Guideline-Recommended Therapy in Non-metastatic Pancreatic Adenocarcinoma. Ann Surg Oncol. e-Pub 2023. PMID: 37543545.
42. De B, Upadhyay R, Liao K, Kumala T, Shi C, Dodoo G, Abi Jaoude J, Corrigan KL, Manzar GS, Marqueen KE, Bernard V, Lee SS, Raghav KPS, Vauthey JN, Tzeng CD, Tran Cao HS, Lee G, Wo JY, Hong TS, Crane CH, Minsky BD, Smith GL, Holliday EB, Taniguchi CM, Koong AC, Das P, Javle M, Ludmir EB, Koay EJ. Definitive Liver Radiotherapy for Intrahepatic Cholangiocarcinoma with Extrahepatic Metastases. Liver Cancer 12(3):198-208, 2023. e-Pub 2023. PMID: 37593365.
43. Vega EA, Newhook TE, Mellado S, Ruzzenente A, Okuno M, De Bellis M, Panettieri E, Ahmad MU, Merlo I, Rojas J, De Rose AM, Nishino H, Sinnamon AJ, Donadon M, Hauger MS, Guevara OA, Munoz C, Denbo JW, Chun YS, Tran Cao HS, Sanchez Claria R, Tzeng CD, De Aretxabala X, Vivanco M, Brudvik KW, Seo S, Pekolj J, Poultsides GA, Torzilli G, Giuliante F, Anaya DA, Guglielmi A, Vinuela E, Vauthey JN. Benchmarks and geographic differences in gallbladder cancer surgery: An International Multi-Center Study. Ann Surg Oncol 30(8):4904-4911, 2023. e-Pub 2023. PMID: 37149547.
44. Ayabe RI, Prakash LR, Bruno ML, Newhook TE, Maxwell JE, Arvide EM, Dewhurst WL, Kim MP, Ikoma N, Snyder RA, Lee JE, Katz MHG, Tzeng CD. Differential Gains in Surgical Outcomes for High-Risk vs Low-Risk Pancreaticoduodenectomy with Successive Refinements of Risk-Stratified Care Pathways. J Am Coll Surg 237(1):4-12, 2023. e-Pub 2023. PMID: 36786469.
45. Ngo-Huang AT, Parker NH, Xiao LC, Schadler KL, Petzel MQB, Prakash LR< Kim MP, Tzeng CWD, Lee JE, Ikoma N, Wolff RA, Javle MM, Koay EJ< Pant SD, Folloder JP, Wang X, Cotto AM, Ju YR, Garg N, wang H, Bruera ED, Basen-Engquist KM, Katz MHG. Effects of a pragmatic home-based exercise program concurrent with neoadjuvant therapy on physical function of patients with pancreatic cancer: the PancFit randomized controlled clinical trial. Ann Surg 278(1):22-30, 2023. PMID: None.
46. Rogers JE, Sirisaengtaksinn A, Morris VK, Xiao L, Huey R, Wolff R, Eng C, Vauthey JN, Tzeng CWD, Johnson B. Hepatic metastasectomy in squamous cell carcinoma of the anal canal: a case series of a curative approach. Cancers(15,):3890, 2023. PMID: None.
47. Liang TZ, Katz MHG, Prakash LR, Chatterjee D, Wang H, Kim M, Tzeng CD, Ikoma N, Wolff RA, Zhao D, Koay EJ, Maitra A, Kundu S, Wang H. Comparative Analyses of the Clinicopathologic Features of Short-Term and Long-Term Survivors of Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and Pancreatoduodenectomy. Cancers (Basel) 15(12), 2023. e-Pub 2023. PMID: 37370842.
48. Maki H, Ayabe RI, Nishioka Y, Konishi T, Newhook TE, Tran Cao HS, Chun YS, Tzeng CD, You YN, Vauthey JN. ASO Author Reflections: The Patient First Approach for Synchronous Liver Metastases from Rectal Cancer. Ann Surg Oncol. e-Pub 2023. PMID: 37322282.
49. Tong YT, Lai Z, Katz MHG, Prakash LR, Wang H, Chatterjee D, Kim M, Tzeng CD, Lee JE, Ikoma N, Rashid A, Wolff RA, Zhao D, Koay EJ, Maitra A, Wang H. Prognosticators for Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Therapy and Pancreatectomy. Cancers (Basel) 15(9):2608, 2023. e-Pub 2023. PMID: 37174073.
50. Erstad DJ, Hatanaka Y, Cass S, Maxwell J, Tran Cao H, Kim M, Tzeng CW, Lee JE, Katz M, Ikoma N. Technique for Robotic Pancreaticojejunostomy. J Am Coll Surg 236(5):e12-e14, 2023. e-Pub 2022. PMID: 36729595.
51. Hirata Y, Maxwell JE, Kim MP, Tzeng CD, Katz MHG, Ikoma N. Transmesocolic Approach for Robotic Duodenal Operations. Ann Surg Oncol 30(5):2959, 2023. e-Pub 2023. PMID: 36752968.
52. Spitzer HV, Bohan PMK, Carpenter EL, Am A, Chang SC, Grunkemeier G, Vreeland TJ, Tzeng CWD, Katz MH, Nelson DW. Impact of adherence to operative standards and stage-specific guideline-recommended therapy in non-metastatic pancreatic adenocarcinoma. Ann Surg Oncol, 2023. PMID: None.
53. Ngo-Huang AT, Parker NH, Xiao LC, Schadler KL, Petzel MQB, Prakash LR, Kim MP, Tzeng CD, Lee JE, Ikoma N, Wolff RA, Javle MM, Koay EJ, Pant SD, Folloder JP, Wang X, Cotto AM, Ju YR, Garg N, Wang H, Bruera ED, Basen-Engquist KM, Katz MHG. Effects of a Pragmatic Home-based Exercise Program Concurrent with Neoadjuvant Therapy on Physical Function of Patients with Pancreatic Cancer: The Pancfit Randomized Clinical Trial. Ann Surg. e-Pub 2023. PMID: 37026453.
54. Sohn AJ, Taherian M, Katz MHG, Prakash LR, Chatterjee D, Wang H, Kim M, Tzeng CD, Lee JE, Ikoma N, Rashid A, Wolff RA, Zhao D, Koay EJ, Sun R, Maitra A, Wang H. Integrated Pathologic Score Effectively Stratifies Patients With Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and Pancreaticoduodenectomy. Am J Surg Pathol 47(4):421-430, 2023. e-Pub 2023. PMID: 36746143.
55. Ayabe RI, Paez-Arango N, Estrella JS, Newhook TE, Tzeng CD, Chun YS, Lee S, Javle M, Vauthey JN, Tran Cao HS. Neoadjuvant chemotherapy for high-risk intrahepatic cholangiocarcinoma - does pathologic response mean better outcomes?. HPB (Oxford) 25(4):472-480, 2023. e-Pub 2023. PMID: 36781357.
56. Newhook TE, Overman MJ, Chun YS, Dasari A, Tzeng CD, Cao HST, Raymond V, Parseghian C, Johnson B, Nishioka Y, Kawaguchi Y, Uppal A, Vreeland TJ, Jaimovich A, Arvide EM, Cristo JV, Wei SH, Raghav KP, Morris VK, Lee JE, Kopetz S, Vauthey JN. Prospective Study of Perioperative Circulating Tumor DNA Dynamics in Patients Undergoing Hepatectomy for Colorectal Liver Metastases. Ann Surg 277(5):813-820, 2023. e-Pub 2022. PMID: 35797554.
57. Kothari AN, Massarweh NN, Flitcroft MA, Newhook T, Tzeng CD, Chun YS, Kaseb AO, Vauthey JN, Tran Cao HS. Evaluating the benefit of surgical resection for hepatocellular carcinoma with multifocality or intrahepatic vascular invasion. HPB (Oxford). e-Pub 2023. PMID: 37085394.
58. Newhook TE, Vreeland TJ, Griffin JF, Tidwell RSS, Prakash LR, Koay EJ, Ludmir EB, Smaglo BG, Pant S, Overman M, Wolff RA, Ikoma N, Maxwell J, Kim MP, Lee JE, Katz MHG, Tzeng CD. Prognosis Associated With CA19-9 Response Dynamics and Normalization During Neoadjuvant Therapy in Resected Pancreatic Adenocarcinoma. Ann Surg 277(3):484-490, 2023. e-Pub 2022. PMID: 36649067.
59. Martin AN, Tzeng CD, Arvide EM, Skibber JM, Chang GJ, Nancy You YQ, Bednarski BK, Uppal A, Dewhurst WL, Cristo JV, Chun YS, Tran Cao HS, Vauthey JN, Newhook TE. Impact of cumulative operative time on postoperative complication risk in simultaneous resections of colorectal liver metastases and primary tumors. HPB (Oxford) 25(3):347-352, 2023. e-Pub 2023. PMID: 36697350.
60. Hester CA, Kothari AN, Mason M, Maxwell J, Ikoma N, Kim MP, Tzeng CD, Lee JE, Katz MHG, Cao HST. Surgical eligibility does not imply surgical equity: recommendations for curative treatment in patients with stage i/ii pancreatic head adenocarcinoma differ by age and race. Ann Surg 277(2):Ann Surg. 2021 Jun 25. doi: 10.1097/SLA.0000000000005033. Epub a, 2023. e-Pub 2023. PMID: 34183508.
61. Aybe RI, Prakash LR, Bruno ML, Newhook TE, Maxwell JE, Arvide EM, Dewhurst WL, Kim MP, Ikoma N, Snyder RA, Lee JE, Katz MHG, Tzeng CWD. Differential gains in surgical outcomes for high-risk vs. low-risk pancreatoduodenectomy with successive refinements of risk-stratified care pathways. J Am Coll Surg. e-Pub 2023. PMID: None.
62. Dodoo GN, De B, Lee SS, Abi Jaoude J, Vauthey JN, Tzeng CD, Tran Cao HS, Katlowitz KA, Mandel JJ, Beckham TH, Minsky BD, Smith GL, Holliday EB, Koong AC, Das P, Taniguchi CM, Javle M, Koay EJ, Ludmir EB. Brain Metastases from Biliary Tract Cancer: Case Series and Clinicogenomic Analysis. Oncologist. e-Pub 2023. PMID: 36715178.
63. Ayabe RI, Paez-Arango N, Esrella JS, Newhook TE, Tzeng CWD, Chun YS, Lee S, Javle M, Vauthey JN, Tran Cao HS. Neoadjuvant chemotherapy for high-risk intrahepatic cholangiocarcinoma – does pathologic response mean better outcomes?. HPB, 2023. PMID: None.
64. Ikoma N, Seo YD, Newhook TE, Maxwell JE, Kim MP, Tran Cao HS, Tzeng CD, Chun YS, Lee JE, Vauthey JN, Katz MHG. Quality of superior mesenteric and hepatic artery dissection in robotic pancreatoduodenectomy for pancreatic cancer. J Hepatobiliary Pancreat Sci 30(1):e1-e2, 2023. e-Pub 2022. PMID: 35950790.
65. Martin AN, Concors SJ, Kim BJ, Newhook TE, Arvide EM, Dewhurst WL, Kawaguchi Y, Tran Cao HS, Katz MHG, Vauthey JN, Tzeng CD. Individual components of post-hepatectomy care pathways have differential impacts on length of stay. Am J Surg 225(1):53-57, 2023. e-Pub 2022. PMID: 36207173.
66. Newton AD, Newhook TE, Ikoma N, Tzeng CD, Chun YS, Vauthey JN, Tran Cao HS. Robotic Extended Right Hepatectomy for Colorectal Liver Metastasis. Ann Surg Oncol 29(13):8455, 2022. e-Pub 2022. PMID: 36112251.
67. Donovan EC, Prakash LR, Chiang YJ, Bruno ML, Maxwell JE, Ikoma N, Tzeng CD, Katz MHG, Lee JE, Kim MP. Incidence of Postoperative Complications Following Pancreatectomy for Pancreatic Cystic Lesions or Pancreatic Cancer. J Gastrointest Surg. e-Pub 2022. PMID: 36443557.
68. DiPeri TP, Newhook TE, Tran Cao HS, Ikoma N, Dewhurst WL, Arvide EM, Bruno ML, Katz MHG, Vauthey JN, Lee JE, Tzeng CD. Opioid discharge prescriptions after inpatient surgery: risks of rebound refills by length of stay. J Surg Res 278:111-118, 2022. e-Pub 2022. PMID: 35597025.
69. Panettieri E, Kim BJ, Kawaguchi Y, Ardito F, Mele C, De Rose AM, Vellone M, Chun YS, Tzeng CD, Aloia TA, Giuliante F, Vauthey JN. Survival by Number and Sites of Resections of Recurrence after First Curative Resection of Colorectal Liver Metastases. J Gastrointest Surg. e-Pub 2022. PMID: 36127553.
70. Morris VK, Overman MJ, Parseghian CM, Johnson B, Dasari A, Raghav K, Kee B Huey RW, Wolff RA, Shen JP, Li J, Zorrilla I, Tzeng CWD, Tran Cao HS, Chun YS, Newhook TE, Vauthey JN, Duose DY, Luthra R, Haymaker CL, Kopetz S. Bintrafusp alfa, an anti-PD-L1:TGF-β trap fusion protein, in patients with ctDNA-positive, liver-limited metastatic colorectal cancer. Cancer Research Communications 2(9):979–986, 2022. e-Pub 2022. PMID: None.
71. Hirata Y, Witt RG, Prakash LR, Arvide EM, Robinson KA, Gottumukkala V, Tzeng CD, Mansfield P, Badgwell BD, Ikoma N. Analysis of Opioid Use in Patients Undergoing Open Versus Robotic Gastrectomy. Ann Surg Oncol 29(9):5861-5870, 2022. e-Pub 2022. PMID: 35507230.
72. Lillemoe HA, Passot G, Kawaguchi Y, DeBellis M, Glehen O, Chun YS, Tzeng CD, Aloia TA, Lopez J, Vauthey JN. RAS/TP53 co-mutation is associated with worse survival after concurrent resection of colorectal liver metastases and extrahepatic disease. Ann Surg 276(2):Online ahead of print, 2022. e-Pub 2020. PMID: 33351476.
73. Hester CA, Perri G, Prakash LR, Maxwell JE, Ikoma N, Kim MP, Tzeng CD, Smaglo B, Wolff R, Javle M, Overman MJ, Lee JE, Katz MHG. Radiographic and Serologic Response to First-Line Chemotherapy in Unresected Localized Pancreatic Cancer. J Natl Compr Canc Netw 20(8):887-897.e3, 2022. PMID: 35948035.
74. Mason MC, Krasnodebski M, Hester CA, Kothari AN, Barker C, Nishioka Y, Chiang YJ, Newhook TE, Tzeng CD, Chun YS, Vauthey JN, Tran Cao HS. Outcomes of Mixed Pathologic Response in Patients with Multiple Colorectal Liver Metastases Treated with Neoadjuvant Chemotherapy and Liver Resection. Ann Surg Oncol 29(8):5156-5164, 2022. e-Pub 2022. PMID: 35397746.
75. Lenet T, Gilbert RWD, Smoot R, Tzeng CD, Rocha FG, Yohanathan L, Cleary SP, Martel G, Bertens KA. ASO Visual Abstract: Does Intraoperative Frozen Section and Revision of Margins Lead to Improved Survival for Patients Undergoing Resection of Perihilar Cholangiocarcinoma? A Systematic Review and Meta-Analysis. Ann Surg Oncol. e-Pub 2022. PMID: 35896924.
76. Schalck A, Sakellariou-Thompson D, Forget MA, Sei E, Hughes TG, Reuben A, Bai S, Hu M, Kumar T, Hurd MW, Katz MHG, Tzeng CD, Pant S, Javle M, Fogelman DR, Maitra A, Haymaker CL, Kim MP, Navin NE, Bernatchez C. Single cell sequencing reveals trajectory of tumor-infiltrating lymphocyte states in pancreatic cancer. Cancer Discov. e-Pub 2022. PMID: 35849783.
77. Koay EJ, Zaid M, Aliru M, Bagereka P, Van Wieren A, Rodriguez MJ, Jacobson G, Wolff RA, Overman M, Varadhachary G, Pant S, Wang H, Tzeng CW, Ikoma N, Kim M, Lee JE, Katz MH, Tamm E, Bhosale P, Taniguchi CM, Holliday EB, Smith GL, Ludmir EB, Minsky BD, Crane CH, Koong AC, Das P, Wang X, Javle M, Krishnan S. Nab-Paclitaxel, Capecitabine, and Radiation Therapy Following Induction Chemotherapy in Treating Patients with Locally Advanced and Borderline Resectable Pancreatic Cancer: Phase I Trial and Imaging-based Biomarker Validation. Int J Radiat Oncol Biol Phys. e-Pub 2022. PMID: 35863672.
78. Gilbert RWD, Lenet T, Cleary SP, Smoot R, Tzeng CD, Rocha FG, Martel G, A Bertens K. ASO Visual Abstract: Does Caudate Resection Improve Outcomes inPatients Undergoing Curative Resection forPerihilar Cholangiocarcinoma? ASystematic Review and Meta-analysis. Ann Surg Oncol. e-Pub 2022. PMID: 35831520.
79. Witt RG, Hirata Y, Prakash LR, Newhook TE, Maxwell JE, Kim MP, Tran Cao HS, Lee JE, Vauthey JN, Katz MHG, Tzeng CD, Ikoma N. Comparative analysis of opioid use between robotic and open pancreatoduodenectomy. J Hepatobiliary Pancreat Sci. e-Pub 2022. PMID: 35796581.
80. Janssen QP, van Dam JL, Prakash LR, Doppenberg D, Crane CH, van Eijck CHJ, Ellsworth SG, Jarnagin WR, O'Reilly EM, Paniccia A, Reyngold M, Besselink MG, Katz MHG, Tzeng CD, Zureikat AH, Groot Koerkamp B, Wei AC, Surgery Consortium TP. Neoadjuvant Radiotherapy After (m)FOLFIRINOX for Borderline Resectable Pancreatic Adenocarcinoma: A TAPS Consortium Study. J Natl Compr Canc Netw 20(7):783-791.e1, 2022. PMID: 35830887.
81. DiPeri TP, Newhook TE, Arvide EM, Dewhurst WL, Bruno ML, Chun YS, Tran Cao HS, Lee JE, Vauthey JN, Tzeng CD. Prospective implementation of standardized post-hepatectomy care pathways to reduce opioid prescription volumes after inpatient surgery. J Am Coll Surg 235(1):41-48, 2022. e-Pub 2022. PMID: 35703961.
82. Witt RG, Newhook TE, Prakash LR, Bruno ML, Arvide EM, Dewhurst WL, Ikoma N, Maxwell JE, Kim MP, Lee JE, Katz MHG, Tzeng CD. Association of patient controlled analgesia and total inpatient opioid use after pancreatectomy. J Surg Res 17(275):244-251, 2022. e-Pub 2022. PMID: 35306260.
83. Kim BJ, Arvide EM, Gaskill C, Martin AN, Kawaguchi Y, Chiang YJ, Dewhurst WL, Lee T, Tran Cao HS, Chun YS, Katz, MHG, Vauthey JN, Tzeng CWD, Newhook TE. Risk-stratified post-hepatectomy pathways based upon the Kawaguchi-Gayet complexity classification and impact on length of stay. Surgery Open Science 9:109-116, 2022. e-Pub 2022. PMID: None.
84. Lenet T, Gilbert RWD, Smoot R, Tzeng CD, Rocha FG, Yohanathan L, Cleary SP, Martel G, Bertens KA. Does Intraoperative Frozen Section and Revision of Margins Lead to Improved Survival in Patients Undergoing Resection of Perihilar Cholangiocarcinoma? A Systematic Review and Meta-analysis. Ann Surg Oncol. e-Pub 2022. PMID: 35752725.
85. DiPeri TP, Newhook TE, Prakash LR, Ikoma N, Maxwell JE, Kim MP, Lee JE, Katz MHG, Tzeng CD. Prognostic significance of preoperative and postoperative CA 19-9 normalization in pancreatic adenocarcinoma treated with neoadjuvant therapy or surgery first. J Surg Oncol. e-Pub 2022. PMID: 35726394.
86. Gilbert RWD, Lenet T, Cleary SP, Smoot R, Tzeng CD, Rocha FG, Martel G, Bertens KA. Does Caudate Resection Improve Outcomes of Patients Undergoing Curative Resection for Perihilar Cholangiocarcinoma? A Systematic Review and Meta-Analysis. Ann Surg Oncol. e-Pub 2022. PMID: 35705775.
87. Hirata Y, Witt RG, Prakash LR, Arvide EM, Robinson KA, Gottumukkala V, Tzeng CD, Mansfield P, Badgwell BD, Ikoma N. ASO Visual Abstract: Analysis of Opioid Use in Patients Undergoing Open Versus Robotic Gastrectomy. Ann Surg Oncol, 2022. e-Pub 2022. PMID: 35771369.
88. Kim BJ, Newhook TE, Tzeng CD, Ikoma N, Chiang YJ, Chun YS, Vauthey JN, Tran Cao HS. Lymphadenectomy and margin-negative resection for biliary tract cancer surgery in the United States-Differential technical performance by approach. J Surg Oncol. e-Pub 2022. PMID: 35578764.
89. Mallick S, Aiken T, Varley P, Abbott D, Tzeng CW, Weber S, Wasif N, Zafar SN. Readmissions from venous thromboembolism after complex cancer surgery. JAMA Surg 157(4):312-320, 2022. e-Pub 2022. PMID: 35080619.
90. Nishioka Y, Chun YS, Overman MJ, Cao HST, Tzeng CD, Mason MC, Kopetz SW, Bauer TW, Vauthey JN, Newhook TE, Program MD. Effect of Co-mutation of RAS and TP53 on Postoperative ctDNA Detection and Early Recurrence after Hepatectomy for Colorectal Liver Metastases. J Am Coll Surg 234(4):474-483, 2022. PMID: 35290266.
91. Mason MC, Krasnodebski M, Hester CA, Kothari AN, Barker C, Nishioka Y, Chiang YJ, Newhook TE, Tzeng CD, Chun YS, Vauthey JN, Tran Cao HS. ASO Visual Abstract: Outcomes of Mixed Pathologic Response in Patients with Multiple Colorectal Liver Metastases Treated with Neoadjuvant Chemotherapy and Liver Resection. Ann Surg Oncol 26:5165-5166. e-Pub 2022. PMID: 35435560.
92. De B, Tran Cao HS, Vauthey JN, Manzar GS, Corrigan KL, Raghav KPS, Lee SS, Tzeng CD, Minsky BD, Smith GL, Holliday EB, Taniguchi CM, Koong AC, Das P, Javle M, Ludmir EB, Koay EJ. Ablative liver radiotherapy for unresected intrahepatic cholangiocarcinoma: Patterns of care and survival in the United States. Cancer 128(13):2529-2539. e-Pub 2022. PMID: 35417569.
93. Kaseb AO, Hasanov E, Cao HST, Xiao L, Vauthey JN, Lee SS, Yavuz BG, Mohamed YI, Qayyum A, Jindal S, Duan F, Basu S, Yadav SS, Nicholas C, Sun JJ, Singh Raghav KP, Rashid A, Carter K, Chun YS, Tzeng CD, Sakamuri D, Xu L, Sun R, Cristini V, Beretta L, Yao JC, Wolff RA, Allison JP, Sharma P. Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial. Lancet Gastroenterol Hepatol 7(3):208-218, 2022. e-Pub 2022. PMID: 35065057.
94. Janssen QP, van Dam JL, Doppenberg D, Prakash LR, van Eijck CHJ, Jarnagin WR, O' Reilly EM, Paniccia A, Besselink MG, Katz MHG, Tzeng CD, Wei AC, Zureikat AH, Groot Koerkamp B, Surgery Consortium TP. FOLFIRINOX as Initial Treatment for Localized Pancreatic Adenocarcinoma: A Retrospective Analysis by the Trans-Atlantic Pancreatic Surgery (TAPS) Consortium. J Natl Cancer Inst. e-Pub 2022. PMID: 35157075.
95. Vreeland TJ, Bohan PMK, Newhook TE, Allen CJ, Prakash LR, Maxwell JE, Ikoma N, Kim MP, Lee JE, Katz MHG, Tzeng CD. Contemporary Assessment of Need for Palliative Bypass After Aborted Pancreatoduodenectomy Following Neoadjuvant Therapy. J Gastrointest Surg 26(2):352-359, 2022. e-Pub 2022. PMID: 35064457.
96. Newton AD, Newhook TE, Bruno ML, Prakash L, Chiang YJ, Paez Arango N, Dewhurst WL, Arvide EM, Ikoma N, Maxwell JE, Kim MP, Lee JE, Katz MHG, Tzeng CWD. Iterative changes in risk-stratified pancreatectomy clinical pathways and accelerated discharge after pancreaticoduodenectomy. J Gastrointest Surg:doi: 10.1007/s11605-021-05235-3, 2022. PMID: None.
97. Kang Y, Deng J, Ling J, Li X, Chiang J, Koay EJ, Wang H, Burks JK, Chiao PJ, Hurd MW, Bhutani MS, Lee JH, Weston B, Maitra A, Ikoma N, Tzeng CWD, Lee JE, DePhinho RA, Wolff RA, Pant S, McAllister F, Katz MHG, Fleming JB, Kim MP. 3D imaging analysis on an organoid-based platform guides personalized treatment in pancreatic ductal adenocarcinoma. J Clin Invest 132(24):e151604, 2022. PMID: None.
98. Witt RG, Cope B, Chiang YJ, Newhook T, Lillemoe H, Tzeng CD, Chen IB, Fisher SB, Lucci A, Wargo JA, Lee JE, Ross MI, Gershenwald JE, Robinson J, Keung EZ. Utilization and evolving prescribing practice of opioid and non-opioid analgesics in patients undergoing lymphadenectomy for cutaneous malignancy. J Surg Oncol. e-Pub 2021. PMID: 34904258.
99. De B, Abu-Gheida I, Patel A, Ng SSW, Zaid M, Thunshelle CP, Elganainy D, Corrigan KL, Rooney MK, Javle M, Raghav K, Lee SS, Vauthey JN, Tzeng CD, Tran Cao HS, Ludmir EB, Minsky BD, Smith GL, Holliday EB, Taniguchi CM, Koong AC, Das P, Koay EJ. Benchmarking outcomes after ablative radiotherapy for molecularly characterized intrahepatic cholangiocarcinoma. J Pers Med 11(12):11, 1270, 2021. e-Pub 2021. PMID: 34945742.
100. Oppliger FA, Prakash LR, Newhook TE, Chiang YJ, Ikoma N, Maxwell JE, Kim MP, Vauthey JN, Lee JE, Katz MH, Tzeng CD. AJCC 8th edition pathologic nodal staging of resected pancreatic adenocarcinoma predicts survival regardless of treatment sequencing. Surg Oncol 40:101673. e-Pub 2021. PMID: 34894620.
101. Nishioka Y, Paez-Arango N, Boettcher FO, Kawaguchi Y, Newhook TE, Chun YS, Tzeng CD, Tran Cao HS, Lee JE, Vreeland TJ, Vauthey JN. Neither surgical margin status nor somatic mutation predicts local recurrence after r0-intent resection for colorectal liver metastases. J Gastrointest Surg. e-Pub 2021. PMID: 34725784.
102. Newton AD, Newhook TE, Ikoma N, White MG, Tzeng CD, Chun YS, Aloia TA, Vauthey JN, Tran Cao HS. Robotic Completion Radical Cholecystectomy with Fluorescence Guidance. Ann Surg Oncol 28(11):6834, 2021. e-Pub 2021. PMID: 33774771.
103. Ikoma N, Kim MP, Tran Cao HS, Prakash LP, Maxwell JE, Tzeng CD, Mansfield PF, Lee JE, Badgwell BD, Katz MHG. Early experience of a robotic foregut surgery program at a cancer center: video of shared steps in robotic pancreatoduodenectomy and gastrectomy. Ann Surg Oncol. e-Pub 2021. PMID: 34515886.
104. Park KM, Rashidian N, Mohamedaly S, Brasel KJ, Conroy P, Glencer AC, He J, Passeri MJ, Katariya NN, Alseidi A, Group TR. Unifying the hepatopancreatobiliary surgery fellowship curriculum via Delphi consensus. J Am Coll Surg 233(3):395-414, 2021. PMID: None.
105. Kawaguchi Y, Kopetz S, Panettieri E, Hwang H, Wang X, Cao HST, Tzeng CD, Chun YS, Aloia TA, Vauthey JN. Improved survival over time after resection of colorectal liver metastases and clinical impact of multigene alteration testing in patients with metastatic colorectal cancer. J Gastrointest Surg. e-Pub 2021. PMID: 34506029.
106. Fonseca AL, Cherla D, Kothari AN, Tzeng CD, Heslin MJ, Mehari KR, Johnston FM, Tran-Cao HS. Association of Medicaid Expansion with Pancreatic Cancer Treatment and Outcomes: Evidence from the National Cancer Database. Ann Surg Oncol. e-Pub 2021. PMID: 34453259.
107. Tong YT, Wang H, Wei D, Prakash LR, Kim M, Tzeng CD, Lee JE, Rashid A, Koay EJ, Wolff RA, Maitra A, Katz MH, Wang H. GRP78 expression and prognostic significance in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant therapy versus surgery first. Pancreatology. e-Pub 2021. PMID: 34429247.
108. Fujii Y, Tzeng CW, Chiang YJ, Halperin DM, Dasari A, Kim MP, Katz MHG, Lee JE, Ikoma N. Incidence of Lymph Node Metastases and Impact of Radical Surgery for Duodenal Neuroendocrine Tumors. J Surg Res 268:419-431. e-Pub 2021. PMID: 34416414.
109. Newhook TE, Prakash LR, Soliz J, Hancher-Hodges S, Speer BB, Wilks JA, Bruno ML, Dewhurst WL, Arvide EM, Maxwell JE, Ikoma N, Kim MP, Lee JE, Katz MHG, Tzeng CD. Perioperative blood transfusions and survival in resected pancreatic adenocarcinoma patients given multimodality therapy. J Surg Oncol. e-Pub 2021. PMID: 34398988.
110. Nishioka Y, Odisio BC, Velasco JD, Ninan E, Huang SY, Mahvash A, Tzeng CD, Tran Cao HS, Gupta S, Vauthey JN. Fast-track two-stage hepatectomy by concurrent portal vein embolization at first-stage hepatectomy in hybrid interventional radiology / operating suite. Surg Oncol 39:101648. e-Pub 2021. PMID: 34438236.
111. Mohindroo C, Hasanov M, Rogers JE, Dong W, Prakash LR, Baydogan S, Mizrahi JD, Overman MJ, Varadhachary GR, Wolff RA, Javle MM, Fogelman DR, Lotze MT, Kim MP, Katz MHG, Pant S, Tzeng CD, McAllister F. Antibiotic use influences outcomes in advanced pancreatic adenocarcinoma patients. Cancer Med 10(15):5041-5050, 2021. e-Pub 2021. PMID: 34250759.
112. Kawaguchi Y, Kopetz S, Kwong L, Xiao L, Morris JS, Tran Cao HS, Tzeng CD, Chun YS, Lee JE, Vauthey JN. Genomic sequencing and insight into clinical heterogeneity and prognostic pathway genes in patients with metastatic colorectal cancer. J Am Coll Surg. e-Pub 2021. PMID: 34111531.
113. Zhao J, Soto LMS, Wang H, Katz MH, Prakash LR, Kim M, Tzeng CD, Lee JE, Wolff RA, Huang Y, Wistuba II, Maitra A, Wang H. Overexpression of CD73 in pancreatic ductal adenocarcinoma is associated with immunosuppressive tumor microenvironment and poor survival. Pancreatology. e-Pub 2021. PMID: 33832821.
114. Kanikarla Marie P, Haymaker C, Parra ER, Kim YU, Lazcano R, Gite S, Lorenzini D, Wistuba II, Tidwell RSS, Song X, Foo WC, Maru DM, Chun YS, Futreal PA, Kee B, Menter D, Solis LM, Tzeng CD, Parseghian CM, Raghav K, Morris VK, Chang CC, Jenq RR, Tam A, Bernatchez C, Kopetz S, Vauthey JN, Overman MJ. Pilot clinical trial of perioperative durvalumab and tremelimumab in the treatment of resectable colorectal cancer liver metastases. Clin Cancer Res. e-Pub 2021. PMID: 33811152.
115. Kawaguchi Y, Kopetz S, Tran Cao HS, Panettieri E, De Bellis M, Nishioka Y, Hwang H, Wang X, Tzeng CD, Chun YS, Aloia TA, Hasegawa K, Guglielmi A, Giuliante F, Vauthey JN. Contour prognostic model for predicting survival after resection of colorectal liver metastases: development and multicentre validation study using largest diameter and number of metastases with RAS mutation status. Br J Surg. e-Pub 2021. PMID: 33829254.
116. Perri G, Prakash L, Wang H, Bhosale P, Varadhachary GR, Wolff R, Fogelman D, Overman M, Pant S, Javle M, Koay E, Herman J, Kim M, Ikoma N, Tzeng CW, Lee JE, Katz MHG. Radiographic and serologic predictors of pathologic major response to preoperative therapy for pancreatic cancer. Ann Surg 273(4):806-813, 2021. e-Pub 2019. PMID: 31274655.
117. Newhook TE, Soliz JM, Prakash LR, Hancher-Hodges S, Speer BB, Wilks JA, Ikoma N, Kim MP, Lee JE, Katz MHG, Tzeng CD. Impact of intraoperative dexamethasone on surgical and oncologic outcomes for patients with resected pancreatic ductal adenocarcinoma. Ann Surg Oncol 28(3):1563-1569, 2021. e-Pub 2020. PMID: 32803553.
118. Kemp Bohan PM, O'Shea AE, Lee AJ, Chick RC, Newhook TE, Tran Cao HS, Allen CJ, Nelson DW, Clifton GT, Vauthey JN, Tzeng CD, Vreeland TJ. Lymph node sampling in resectable hepatocellular carcinoma: national practice patterns and predictors of positive lymph nodes. Surg Oncol 36:138-146, 2021. e-Pub 2020. PMID: 33418464.
119. Newhook TE, Tzeng CD. ASO Author Reflections: Tumor biology and safe surgery remain major determinants of survival after resection of pancreatic adenocarcinoma. Ann Surg Oncol 28(3):1570-1571, 2021. e-Pub 2020. PMID: 32880772.
120. Vega EA, Newhook TE, Kawaguchi Y, Qiao W, De Bellis M, Okuno M, Panettieri E, Nishino H, Duwe G, Piccino M, De Rose AM, Ruzzenente A, Uemoto S, Vivanco M, Chun YS, Cao HST, Tzeng CD, De Aretxabala X, Seo S, Giuliante F, Guglielmi A, Vinuela E, Vauthey JN. Conditional recurrence-free survival after oncologic extended resection for gallbladder cancer: an international multicenter analysis. Ann Surg Oncol:Online ahead of print, 2021. e-Pub 2021. PMID: 33666814.
121. Kim BJ, Newhook TE, Blumenthaler A, Chiang YJ, Aloia TA, Roland CL, Katz MHG, Vauthey JN, Lee JE, Tzeng CWD. Sustained reduction in discharge opioid volumes through provider education: Results of 1168 cancer surgery patients over 2 years. J Surg Oncol:Online ahead of print, 2021. PMID: 33751605.
122. Mason MC, Tzeng CD, Tran Cao HS, Aloia TA, Newhook TE, Overman MJ, Kopetz SE, Vauthey JN, Chun YS. Preliminary analysis of liquid biopsy after hepatectomy for colorectal liver metastases. J Am Coll Surg:S1072-7515(21)00162-9, 2021. e-Pub 2021. PMID: 33667566.
123. Allen CJ, Eska JS, Thaker NG, Feeley TW, Kaplan RS, Huey RW, Tzeng CD, Lee JE, Frank SJ, Aloia TA, Gottumukkala V, Katz MHG. Developing a value framework: utilizing administrative data to assess an enhanced care initiative. J Surg Res 262:115-120. e-Pub 2021. PMID: 33561722.
124. Denbo JW, Kim BJ, Vauthey JN, Tzeng CW, Ma J, Huang SY, Chun YS, Katz MHG, Aloia TA. Overall body composition and sarcopenia are associated with poor liver hypertrophy following portal vein embolization. J Gastrointest Surg 25(2):405-410, 2021. e-Pub 2020. PMID: 31997073.
125. White MG, Tzeng CW, Ikoma N, Chun YS, Aloia TA, Vauthey JN, Cao HST. Robotic Partial Segment VIII Resection. Ann Surg Oncol 28(3):1513, 2021. PMID: 32761429.
126. Bohan K, O'Shea A, Chick R, Bader J, Newhook T, Clifton GT, Tzeng CW. Rates, predictors, and outcomes of portal lymphadenectomy for resectable gallbladder cancer. Ann Surg Oncol:Online ahead of print, 2021. e-Pub 2021. PMID: 33566248.
127. Mason MC, Massarweh NN, Tzeng CD, Chiang YJ, Chun YS, Aloia TA, Javle M, Vauthey JN, Tran Cao HS. Time to rethink upfront surgery for resectable intrahepatic cholangiocarcinoma? Implications from the neoadjuvant experience. Ann Surg Oncol. e-Pub 2021. PMID: 33586068.
128. White MG, Lee A, Vicente D, Hall C, Kim MP, Katz MHG, Lee JE, Ikoma N, Lucci A, Tzeng CD. Measurement of portal vein blood circulating tumor cells is safe and may correlate with outcomes in resected pancreatic ductal adenocarcinoma. Ann Surg Oncol. e-Pub 2021. PMID: 33415562.
129. Kawaguchi Y, Newhook TE, Tran Cao HS, Tzeng CD, Chun YS, Aloia TA, Dasari A, Kopetz S, Vauthey JN. Alteration of FBXW7 is associated with worse survival in patients undergoing resection of colorectal liver metastases. J Gastrointest Surg 25(1):186-194, 2021. e-Pub 2020. PMID: 33205306.
130. Wei D, Zaid MM, Katz MH, Prakash LR, Kim M, Tzeng CD, Lee JE, Agrawal A, Rashid A, Wang H, Varadhachary G, Wolff RA, Tamm EP, Bhosale PR, Maitra A, Koay EJ, Wang H. Clinicopathological correlation of radiologic measurement of post-therapy tumor size and tumor volume for pancreatic ductal adenocarcinoma. Pancreatology 21(1):200-207, 2021. e-Pub 2020. PMID: 33221151.
131. Bohan PM, O'Shea AE, Lee AJ, Chick RC, Newhook TE, Tran Cao HS, Allen CJ, Nelson DW, Clifton GT, Vauthey JN, Tzeng CWD, Vreeland TJ. Lymph node sampling in resectable hepatocellular carcinoma: national practice patterns and predictors of positive lymph nodes  . Surg Oncol 36:136-146, 2021. e-Pub 2020. PMID: None.
132. Hoffe S, Frakes JM, Aguilera TA, Czito B, Palta M, Brookes M, Schweizer C, Colbert L, Moningi S, Bhutani MS, Pant S, Tzeng CW, Tidwell RS, Thall P, Yuan Y, Moser EC, Holmlund J, Herman J, Taniguchi CM. Randomized, Double-Blinded, Placebo-controlled Multicenter Adaptive Phase 1-2 Trial of GC 4419, a Dismutase Mimetic, in Combination with High Dose Stereotactic Body Radiation Therapy (SBRT) in Locally Advanced Pancreatic Cancer (PC). Int J Radiat Oncol Biol Phys 108(5):1399-1400, 2020. e-Pub 2020. PMID: 33427657.
133. De Bellis M, Kawaguchi Y, Duwe G, Tran Cao HS, Mehran RJ, Vauthey JN. Short- and long-term outcomes of a transdiaphragmatic approach for simultaneous resection of colorectal liver and lung metastases. J Gastrointest Surg 25(3):641-649, 2020. e-Pub 2020. PMID: 33123875.
134. Kawaguchi Y, Kopetz S, Lillemoe HA, Hwang H, Wang X, Tzeng CWD, Chun YS, Aloia TA, Vauthey JN. A new surveillance algorithm after resection of colorectal liver metastases based on changes in recurrence risk and RAS mutation status. JNCCN 18(11):1-10, 2020. PMID: None.
135. Lillemoe HA, Newhook TE, Aloia TA, Grubbs EG, Chang GJ, Katz MHG, Vauthey JN, Lee JE, Tzeng CD. Perceptions of opioid use and prescribing habits in oncologic surgery: A survey of the society of surgical oncology membership. J Surg Oncol 122(6):1066-1073, 2020. e-Pub 2020. PMID: 32632993.
136. Colina A, Hwang H, Wang H, Katz MHG, Sun R, Lee JE, Thomas J, Tzeng CW, Wolff RA, Raghav K, Overman MJ. Natural history and prognostic factors for localised small bowel adenocarcinoma. ESMO Open 5(6), 2020. PMID: 33188051.
137. Arango NP, Prakash LR, Chiang YJ, Dewhurst WL, Bruno ML, Ikoma N, Kim MP, Lee JE, Katz MHG, Tzeng CD. Risk-stratified pancreatectomy clinical pathway implementation and delayed gastric emptying. J Gastrointest Surg:Online ahead of print, 2020. e-Pub 2020. PMID: 33236322.
138. Abdel-Wahab R, Hassan MM, George B, Carmagnani Pestana R, Xiao L, Lacin S, Yalcin S, Shalaby AS, Al-Shamsi HO, Raghav K, Wolff RA, Yao JC, Girard L, Haque A, Duda DG, Dima S, Popescu I, Elghazaly HA, Vauthey JN, Aloia TA, Tzeng CW, Chun YS, Rashid A, Morris JS, Amin HM, Kaseb AO. Impact of Integrating Insulin-Like Growth Factor 1 Levels into Model for End-Stage Liver Disease Score for Survival Prediction in Hepatocellular Carcinoma Patients. Oncology 98(12):836-846, 2020. e-Pub 2020. PMID: 33027788.
139. Kim BJ, Chiang YJ, Das P, Minshy BD, Blum MA, Ajani JA, Estrella JS, Hofstetter WL, Tzeng CWD, Badgwell BD, Mansfield PF, Ikoma N. Treatment patterns for gastroesophageal junction adenocarcinoma in the United States. J Clin Med 9, 2020. PMID: None.
140. Chun YS, Mizuno T, Cloyd JM, Ha MJ, Omichi K, Tzeng CD, Aloia TA, Ueno NT, Kuerer HM, Barcenas CH, Vauthey JN. Hepatic resection for breast cancer liver metastases: Impact of intrinsic subtypes. Eur J Surg Oncol 46(9):1588-1595, 2020. e-Pub 2020. PMID: 32253074.
141. Tzeng CWD, Cao T, HS, Roland CL, Teshome M, Bednarski BK, Ikoma N, Graham PH, Keung EZ, Scally CP, Katz MHG, Gershenwald JE, Lee JE, Vauthey JN. Surgical decision-making and prioritization for cancer patients at the onset of the COVID-19 pandemic: A multidisciplinary approach. Surg Oncol 34:182-185, 2020. e-Pub 2020. PMID: 32891326.
142. Kim BJ, Lillemoe HA, Newhook TE, Dewhurst WL, Arvide EM, Katz MHG, Aloia TA, Vauthey JN, Lee JE, Tzeng CD. Educating surgical oncology providers on perioperative opioid use: A departmental survey 1 year after the intervention. J Surg Oncol 122(3):547-554, 2020. e-Pub 2020. PMID: 32447769.
143. Kemp Bohan PM, Chick RC, Wall ME, Hale DF, Tzeng CD, Peoples GE, Vreeland TJ, Clifton GT. An educational intervention reduces opioids prescribed following general surgery procedures. J Surg Res 257:399-405. e-Pub 2020. PMID: 32892137.
144. Day RW, Newhook TE, Dewhurst WL, Arvide EM, Bruno ML, Vauthey JN, Tzeng CD. Assessing the 5×-multiplier calculation to reduce discharge opioid prescription volumes after inpatient surgery. JAMA Surg 15(12):1166-1167. e-Pub 2020. PMID: 32997105.
145. Tran Cao HS, Tzeng CW, Chun YS, Aloia TA, Vauthey JN. Surgical management of localized hepatocellular carcinoma in times of crisis: a strategic approach to resource utilization. J Hepatocell Carcinoma 28(7):155-158, 2020. PMID: 33062624.
146. Tzeng CWD, Teshome M, Katz MHG, Weinberg JS, Lai SY, Antonoff MB, Bird JE, Shafer A, Davis JW, Adelman DM, Moon B, Reece G, Prabhu SS, DeSNyder SM, Skibber JM, Mehran R, Schmeler K, Roland CL, Tran Cao HS, Aloia TA, Caudle AS, Swisher SG, Vauthey JN. Cancer surgery scheduling during and after the COVID-19 First Wave: The MD Anderson Cancer Center Experience. Ann Surg 272(2):e106-e111, 2020. e-Pub 2020. PMID: None.
147. Day RW, Taylor BM, Bednarski BK, Tzeng CD, Gershenwald JE, Lee JE, Grubbs EG. Virtual Interviews for Surgical Training Program Applicants During COVID-19: Lessons Learned and Recommendations. Ann Surg 272(2):e144-e147, 2020. PMID: 32675519.
148. Ikoma N, Kim MP, Tzeng CD, Tran Cao HS, Lee JE, Katz MHG. External Retraction Technique for Robotic Pancreatoduodenectomy. J Am Coll Surg 231(5):e8–e10. e-Pub 2020. PMID: 32805403.
149. White MG, Tzeng CW, Ikoma N, Chun YS, Aloia TA, Vauthey JN, Cao HST. Robotic Partial Segment VIII Resection. Ann Surg Oncol 28(3):1513, 2020. e-Pub 2020. PMID: 32761429.
150. Shah MM, Meyer BI, Rhee K, NeMoyer RE, Lin Y, C-WD T, Jabbour SK, Kennedy TJ, Nosher JL, Kooby DA, Maithel SK, Carpizo DR. Conditional survival analysis of hepatocellular carcinoma. J Surg Oncol 122(4):684-690, 2020. PMID: None.
151. Joechle K, Vreeland TJ, Vega EA, Okuno M, Newhook TE, Panettieri E, Chun YS, Tzeng CD, Aloia TA, Lee JE, Vauthey JN. Anatomic Resection Is Not Required for Colorectal Liver Metastases with RAS Mutation. J Gastrointest Surg 24(5):1033-1039, 2020. e-Pub 2020. PMID: 32162236.
152. Nishioka Y, Tzeng CD, Tran Cao HS, Vauthey JN. COVID-19 outbreak and surgeonsresponse at a Cancer Center in the United States. Glob Health Med 2(2):135-137, 2020. PMID: 33330793.
153. Cloyd JM, Mizuno T, Kawaguchi Y, Lillemoe HA, Karagkounis G, Omichi K, Chun YS, Conrad C, Tzeng CD, Odisio BC, Huang SY, Hicks M, Wei SH, Aloia TA, Vauthey JN. Comprehensive complication index validates improved outcomes over time despite increased complexity in 3707 consecutive hepatectomies. Ann Surg 271(4):724-734, 2020. e-Pub 2018. PMID: 30339628.
154. Perri G, Prakash L, Malleo G, Caravati A, Varadhachary GR, Fogelman D, Pant S, Koay EJ, Herman J, Maggino L, Milella M, Kim M, Ikoma N, Tzeng CW, Salvia R, Lee JE, Bassi C, Katz MHG. The sequential radiographic effects of preoperative chemotherapy and (chemo)radiation on tumor anatomy in patients with localized pancreatic cancer. Ann Surg Oncol 27(10):3939-3947, 2020. e-Pub 2020. PMID: 32266574.
155. Okuno M, Newhook TE, Joechle K, Kawaguchi Y, De Bellis M, Tzeng CD, Chun YS, Aloia TA, Shindoh J, Kaseb AO, Vauthey JN. Characteristics of atypical large well-differentiated hepatocellular carcinoma: a specific subtype of hepatocellular carcinoma?. HPB (Oxford) 22(4):545-552, 2020. e-Pub 2019. PMID: 31533893.
156. Perri G, Prakash L, Qiao W, Varadhachary G, Wolff R, Fogelman D, Overman M, Pant S, Jvale M, Koay EJ, Herman J, Kim, M, Ikoma N, Tzeng CW, Lee JE, Katz MHG. Response to and survival after first-line FOLFIRINOX or gemcitabine/nab-paclitaxel for localized pancreatic ductal adenocarcinoma. JAMA Surg 155(9):832-839, 2020. PMID: 32667641.
157. Niekamp AS, Huang SY, Mahvash A, Odisio BC, Ahrar K, Tzeng CD, Vauthey JN. Hepatic vein embolization after portal vein embolization to induce additional liver hypertrophy in patients with metastatic colorectal carcinoma. Eur Radiol 30(7):3862-3868, 2020. e-Pub 2020. PMID: 32144462.
158. Prakash LR, Wang H, Zhao J, Nogueras-Gonzalez GM, Cloyd JM, Tzeng CD, Kim MP, Lee JE, Katz MHG. Significance of cancer cells at the vein edge in patients with pancreatic adenocarcinoma following pancreatectomy with vein resection. J Gastrointest Surg 24(2):368-379, 2020. e-Pub 2019. PMID: 30820801.
159. Newhook TE, Dewhurst WL, Vreeland TJ, Wang X, Soliz J, Speer BB, Hodges SH, Feng C, Bruno ML, Kim MP, Aloia TA, Vauthey JN, Lee JE, Katz MHG, Tzeng CWD. Inpatient opioid use after pancreatectomy: opportunities for reducing initial opioid exposure in cancer surgery patients. Ann Surg Oncol 26(11):3428-3435, 2020. PMID: None.
160. Newhook TE, Vega EA, Vreeland TJ, Prakash L, Dewhurst WL, Bruno ML, Kim MP, Ikoma N, Vauthey JN, Katz MH, Lee JE, Tzeng CD. Early postoperative drain fluid amylase in risk-stratified patients promotes tailored post-pancreatectomy drain management and potential for accelerated discharge. Surgery 167(2):442-447, 2020. e-Pub 2019. PMID: 31727324.
161. Newhook TE, Vreeland TJ, Dewhurst WL, Arvide EM, Bruno ML, Robinson KA, Rajkot N, Aloia TA, Katz MHG, Vauthey JN, Lee JE, Tzeng CWD. Opioid prescribing practices after oncologic surgery: opportunities for improvement and a call to action. Ann Surg 271(2):e9-e10, 2020. PMID: None.
162. Parker NH, Lee RE, O'Connor DP, Ngo-Huang A, Petzel MQB, Schadler K, Wang X, Xiao L, Fogelman D, Simpson R, Fleming JB, Lee JE, Tzeng CD, Sahai SK, Basen-Engquist K, Katz MHG. Supports and barriers to home-based physical activity during preoperative treatment of pancreatic cancer: A mixed-methods study. J Phys Act Health 16(12):1113-1122, 2019. e-Pub 2019. PMID: 31592772.
163. Simoneau E, Katz MH, Lee JE, Tzeng CD. ASO author reflections: temporary mesocaval shunt: Indications and technique for safe resection of pancreatic tumors with mesenteric venous occlusion. Ann Surg Oncol 26(Suppl 3):579-580, 2019. e-Pub 2019. PMID: 30859352.
164. Vega EA, De Aretxabala X, Qiao W, Newhook TE, Okuno M, Castillo F, Sanhueza M, Diaz C, Cavada G, Jarufe N, Munoz C, Rencoret G, Vivanco M, Joechle K, Tzeng CD, Vauthey JN, Vinuela E, Conrad C. Comparison of oncological outcomes after open and laparoscopic re-resection of incidental gallbladder cancer. Br J Surg 107(3):289-300, 2019. e-Pub 2019. PMID: 31873948.
165. Perri G, Prakash L, Qiao W, Vardhachary GR, Wolff R, Fogelman D, Overman M, Pant S, Javle M, Koay EJ, Herman J, Kim M, Ikoma N, Tzeng CW, Lee JE, Katz MH. Postoperative chemotherapy benefits patients who received preoperative therapy and pancreatectomy for pancreatic adenocarcinoma. Ann Surg 271(6):996-1002. e-Pub 2019. PMID: None.
166. Kawaguchi Y, Hasegawa K, Tzeng CD, Mizuno T, Arita J, Sakamoto Y, Chun YS, Aloia TA, Kokudo N, Vauthey JN. Performance of a modified three-level classification in stratifying open liver resection procedures in terms of complexity and postoperative morbidity. Br J Surg 107(3):258-267, 2019. e-Pub 2019. PMID: 31603540.
167. Keung EZ, Asare E, Chiang YJ, Prakash L, Rajkot N, Torres KE, Hunt KK, Feig BW, Cormier JN, Roland CL, Katz MHG, Lee JE, Tzeng CWE. Postoperative pancreatic fistula after distal pancreatectomy for non-pancreas retroperitoneal tumor resection. Am J Surg 220(1):140-146, 2019. e-Pub 2019. PMID: 31843190.
168. Kawaguchi Y, Chiang YJ, Velasco JD, Tzeng CWD, Vauthey JN. Long-term outcomes in patients undergoing resection, ablation, and trans-arterial chemoembolization of hepatocellular carcinoma in the United States: a national cancer database analysis. GHM 11(1):55-60, 2019. PMID: None.
169. Kawaguchi Y, Kopetz S, Newhook TE, De Bellis M, Chun YS, Tzeng CD, Aloia TA, Vauthey JN. Mutation status of RAS, TP53, and SMAD4 is superior to mutation status of RAS alone for predicting prognosis after resection of colorectal liver metastases. Clin Cancer Res 25(19):5843-5851, 2019. e-Pub 2019. PMID: 31221662.
170. Kawaguchi Y, Lillemoe HA, Panettieri E, Chun YS, Tzeng CW, Aloia TA, Kopetz S, Vauthey JN. Conditional recurrence-free survival after resection of colorectal liver metastases: Persistent deleterious association with RAS and TP53 Co-mutation. J Am Coll Surg 229(3):286-294.e1, 2019. e-Pub 2019. PMID: 31054911.
171. Riquelme E, Zhang Y, Zhang L, Montiel M, Zoltan M, Dong W, Quesada P, Sahin I, Chandra V, San Lucas A, Scheet P, Xu H, Hanash SM, Feng L, Burks JK, Do KA, Peterson CB, Nejman D, Tzeng CD, Kim MP, Sears CL, Ajami N, Petrosino J, Wood LD, Maitra A, Straussman R, Katz M, White JR, Jenq R, Wargo J, McAllister F. Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes. Cell 178(4):795-806.e12, 2019. PMID: 31398337.
172. Vega EA, Vinuela E, Okuno M, Joechle K, Sanhueza M, Diaz C, Jarufe N, Martinez J, Troncoso A, Diaz A, Chun YS, Tzeng CD, Lee JE, Vauthey JN, Conrad C. Incidental versus non-incidental gallbladder cancer: index cholecystectomy before oncologic re-resection negatively impacts survival in T2b tumors. HPB (Oxford) 21(8):1046-1056, 2019. e-Pub 2019. PMID: 30711243.
173. Vreeland TJ, Beaudry Simoneau E, Dewhurst WL, Newhook TE, Westin SN, Mehran RJ, Chun YS, Aloia TA, Vauthey JN, Tzeng CD. Intraoperative air leak test to prevent bile leak after right posterior sectionectomy with en bloc diaphragm resection for metastatic teratoma. Ann Surg Oncol 26(8):2579, 2019. e-Pub 2019. PMID: 31065963.
174. Vreeland TJ, McAllister F, Javadi S, Prakash LR, Fogelman DR, Ho L, Varadhachary G, Aloia TA, Vauthey JN, Lee JE, Kim MP, Katz MHG, Tzeng CD. Benefit of gemcitabine/Nab-paclitaxel rescue of patients with borderline resectable or locally advanced pancreatic adenocarcinoma after early failure of FOLFIRINOX. Pancreas 48(6):837-843, 2019. PMID: 31210666.
175. Cloyd JM, Prakash L, Vauthey JN, Aloia TA, Chun YS, Tzeng CW, Kim MP, Lee JE, Katz MHG. The role of preoperative therapy prior to pancreatoduodenectomy for distal cholangiocarcinoma. Am J Surg 218(1):145-150, 2019. e-Pub 2018. PMID: 30224070.
176. Lillemoe HA, Newhook TE, Vreeland TJ, Arvide EM, Dewhurst WL, Grubbs EG, Aloia TA, Vauthey JN, Lee JE, Tzeng CD. Educating surgical oncology providers on perioperative opioid use: results of a departmental survey on perceptions of opioid needs and prescribing habits. Ann Surg Oncol 26(7):2011-2018, 2019. e-Pub 2019. PMID: 30937660.
177. Vega EA, Vinuela E, Sanhueza M, Mege R, Caracci M, Diaz C, Diaz A, Okuno M, Joechle K, Goumard C, Chun YS, Tzeng CD, Lee JE, Vauthey JN, Conrad C. Positive cystic duct margin at index cholecystectomy in incidental gallbladder cancer is an important negative prognosticator. Eur J Surg Oncol 45(6):1061-1068, 2019. e-Pub 2019. PMID: 30704808.
178. Vicente D, Lee AJ, Hall CS, Lucci A, Lee JE, Kim MP, Katz MH, Hurd MW, Maitra A, Rhim Md AD, Tzeng CD. Circulating tumor cells and transforming growth factor beta in resected pancreatic adenocarcinoma. J Surg Res 243:90-99. e-Pub 2019. PMID: 31170555.
179. Bhutani MS, Cazacu IM, Luzuriaga Chavez AA, Singh BS, Wong FCL, Erwin WD, Tamm EP, Mathew GG, Le DB, Koay EJ, Taniguchi CM, Minsky BD, Pant S, Tzeng CD, Koong AC, Varadhachary GR, Katz MHG, Wolff RA, Fogelman DR, Herman JM. Novel EUS-guided brachytherapy treatment of pancreatic cancer with phosphorus-32 microparticles: first United States experience. VideoGIE 4(5):223-225, 2019. e-Pub 2019. PMID: 31065616.
180. Chun YS, Passot G, Yamashita S, Nusrat M, Katsonis P, Loree JM, Conrad C, Tzeng CW, Xiao L, Aloia TA, Eng C, Kopetz SE, Lichtarge O, Vauthey JN. Deleterious effect of RAS and evolutionary high-risk TP53 double mutation in colorectal liver metastases. Ann Surg 269(5):917-923, 2019. e-Pub 2017. PMID: 28767562.
181. Bernard V, Semaan A, Huang J, San Lucas FA, Mulu FC, Stephens BM, Guerrero PA, Huang Y, Zhao J, Kamyabi N, Sen S, Scheet PA, Taniguchi CM, Kim MP, Tzeng CW, Katz MH, Singhi AD, Maitra A, Alvarez HA. Single-cell transcriptomics of pancreatic cancer precursors demonstrates epithelial and microenvironmental heterogeneity as an early event in neoplastic progression. Clin Cancer Res 25(7):2194-2205, 2019. e-Pub 2018. PMID: 30385653.
182. Okuno M, Goumard C, Kopetz S, Vega EA, Joechle K, Mizuno T, Tzeng CD, Chun YS, Lee JE, Vauthey JN, Aloia TA, Conrad C. Loss of muscle mass during preoperative chemotherapy as a prognosticator for poor survival in patients with colorectal liver metastases. Surgery 165(2):329-336, 2019. e-Pub 2018. PMID: 30197278.
183. Simoneau E, Goumard C, Lee JE, Vauthey JN, Aloia TA, Chun YS, Kim MP, Katz MHG, Tzeng CD. Pancreaticoduodenectomy with mesocaval shunt for locally advanced pancreatic adenocarcinoma. Ann Surg Oncol 26(2):652, 2019. e-Pub 2018. PMID: 30539487.
184. Cloyd JM, Chen HC, Wang X, Tzeng CD, Kim MP, Aloia TA, Vauthey JN, Lee JE, Katz MHG. Chemotherapy versus chemoradiation as preoperative therapy for resectable pancreatic ductal adenocarcinoma: a propensity score adjusted analysis. Pancreas 48(2):216-222, 2019. PMID: 30629022.
185. Lee AJ, Simoneau E, Chiang YJ, Lee JE, Kim MP, Aloia TA, Vauthey JN, Katz MH, Tzeng CD. Is early-stage pancreatic adenocarcinoma truly early: stage migration on final pathology with surgery-first versus neoadjuvant therapy sequencing. HPB (Oxford) 21(9):1203-1210, 2019. e-Pub 2019. PMID: 30799277.
186. Vicente D, Patino M, Marcus R, Lillmoe H, Limani P, Newhook T, Lee A, Tzeng CW, Segraves-Chun Y, Tweardy D, Gottumukkala V, Vauthey JN, Aloia T, Cata JP. Impact of epidural analgesia on the systemic biomarker response after hepatic resection. Oncotarget 10(5):584-594, 2019. e-Pub 2019. PMID: 30728909.
187. Lillemoe HA, Kawaguchi Y, Passot G, Karagkounis G, Simoneau E, You YN, Mehran RJ, Chun YS, Tzeng CD, Aloia TA, Vauthey JN. Surgical resection for recurrence after two-stage hepatectomy for colorectal liver metastases is feasible, is safe, and improves survival. J Gastrointest Surg 23(1):84-92, 2019. e-Pub 2018. PMID: 30084064.
188. Ogiso S, Okuno M, Shindoh J, Sakamoto Y, Mizuno T, Araki K, Goumard C, Nomi T, Ishii T, Uemoto S, Chun YS, Tzeng CW, Lee JE, Vauthey JN, Conrad C. Conceptual framework of middle hepatic vein anatomy as a roadmap for safe right hepatectomy. HPB (Oxford) 21(1):43-50, 2019. PMID: None.
189. Cazacu IM, Singh BS, Tzeng CD, Tamm EP, Bhutani MS. Is it tumor encasement or arterial dissection/thrombosis? EUS to the rescue!. VideoGIE 4(1):24-26, 2019. e-Pub 2019. PMID: 30623155.
190. Joechle K, Vega EA, Okuno M, Simoneau E, Ogiso S, Newhook TE, Ramirez DL, Holmes AA, Soliz JM, Chun YS, Tzeng CD, Lee JE, Vauthey JN, Conrad C. Middle hepatic vein roadmap for a safe laparoscopic right hepatectomy. Ann Surg Oncol 26(1):296, 2019. e-Pub 2018. PMID: 30465224.
191. Lee AJ, Loyer EM, Kang HC, Aloia TA, Tzeng CD, Vauthey JN, Chun YS. Intrahepatic Recurrence Patterns Predict Survival After Resection of Colorectal Liver Metastases. Ann Surg Oncol 26(1):275-281, 2019. e-Pub 2018. PMID: 30362064.
192. Kim BJ, Prakash L, Narula N, Davis CH, Kim MP, Aloia TA, Vauthey JN, Lee JE, Katz MH, Tzeng CWD. Contemporary analysis of complications associated with biliary stents during neoadjuvant therapy for pancreatic adenocarcinoma. HPB (Oxford) 21(6):662-668, 2018. e-Pub 2018. PMID: 30522947.
193. Snyder RA, Prakash LR, Nogueras-Gonzalez GM, Kim MP, Aloia TA, Vauthey JN, Lee JE, Fleming JB, Katz MHG, Tzeng CW. Perioperative blood transfusions for vein resection during pancreaticoduodenectomy for pancreatic adenocarcinoma: identification of clinical targets for optimization. HPB (Oxford) 21(7):841-848, 2018. PMID: 30501986.
194. Newhook TE, Vreeland TJ, Dewhurst WL, Wang X, Prakash L, Feng C, Bruno ML, Kim MP, Aloia TA, Vauthey JN, Lee JE, Katz MHG, Tzeng CWD. Clinical factors associated with practice variation in discharge opioid prescriptions after pancreatectomy. Ann Surg 272(1):163-169, 2018. e-Pub 2018. PMID: None.
195. Lee AJ, Chiang YJ, Lee JE, Conrad C, Chun YS, Aloia TA, Vauthey JN, Tzeng CD. Validation of American Joint Committee on Cancer Eighth Staging System for gallbladder cancer and its lymphadenectomy guidelines. J Surg Res 230:148-154, 2018. e-Pub 2018. PMID: 30100032.
196. Gulhati P, Prakash L, Katz MHG, Wang X, Javle M, Shroff R, Fogelman D, Lee JE, Tzeng CWD, Lee JH, Weston B, Tamm E, Bhosale P, Koay EJ, Maitra A, Wang H, Wolff RA, Varadhachary GR. First-line gemcitabine and Nab-paclitaxel Chemotherapy for localized pancreatic ductal adenocarcinoma. Ann Surg Oncol 26(2):619-627, 2018. PMID: None.
197. Denbo JW, Bruno M, Dewhurst W, Kim MP, Tzeng CW, Aloia TA, Soliz J, Speer BB, Lee JE, Katz MHG. Risk-stratified clinical pathways decrease the duration of hospitalization and costs of perioperative care after pancreatectomy. Surgery 164(3):424-431, 2018. e-Pub 2018. PMID: 29807648.
198. Elganainy D, Holliday EB, Taniguchi CM, Smith GL, Shroff R, Jalve M, Raghav K, Kaseb A, Aloia TA, Vauthey JN, Tzeng CWD, Herman JM, Koong AC, Krishnan SX, Minsky BD, Crane CH, Das P, Koay EJ. Dose escalation of radiotherapy in unresectable extrahepatic cholangiocarcinoma. Cancer Med 7(10):4880-4892, 2018. e-Pub 2018. PMID: 30152073.
199. Okuno M, Goumard C, Kopetz S, Vega EA, Joechle K, Mizuno T, Omichi K, Tzeng CD, Chun YS, Vauthey JN, Conrad C. RAS mutation is associated with unsalvageable recurrence following hepatectomy for colorectal cancer liver metastases. Ann Surg Oncol 25(8):2457-2466, 2018. e-Pub 2018. PMID: 29786130.
200. Joechle K, Goumard C, Vega EA, Okuno M, Chun YS, Tzeng CD, Vauthey JN, Conrad C. Long-term survival after post-hepatectomy liver failure for colorectal liver metastases. HPB (Oxford) 21(3):361-369, 2018. e-Pub 2018. PMID: 30100391.
201. Katz MH, Kim MP, Tzeng CW, Lee JE. Preoperative chemoradiation for borderline resectable pancreatic cancer: The new standard?. Ann Surg 268(2):223-224, 2018. e-Pub 2018. PMID: 29672417.
202. Peterson SL, Husnain M, Pollack T, Pimentel A, Loaiza-Bonilla A, Westendorf-Overley C, Ratermann K, Anthony L, Desimone P, Goel G, Kudrimoti M, Dineen S, Tzeng CD, Hosein PJ. Neoadjuvant Nab-paclitaxel and gemcitabine in borderline resectable or locally advanced unresectable pancreatic adenocarcinoma in patients who are ineligible for FOLFIRINOX. Anticancer Res 38(7):4035-4039, 2018. PMID: 29970528.
203. Lam A, Heslin MJ, Tzeng CD, Chen H. The effects of tenure and promotion on surgeon productivity. J Surg Res 227:67-71, 2018. e-Pub 2018. PMID: 29804864.
204. Vicente D, Ikoma N, Chiang YJ, Fournier K, Tzeng CD, Song S, Mansfield P, Ajani J, Badgwell BD. Preoperative therapy for gastric adenocarcinoma is protective for poor oncologic outcomes in patients with complications after gastrectomy. Ann Surg Oncol 25(9):2720-2730. e-Pub 2018. PMID: 29987602.
205. Snyder RA, Prakash LR, Nogueras-Gonzalez GM, Kim MP, Aloia TA, Vauthey JN, Lee JE, Fleming JB, Katz MHG, Tzeng CW. Vein resection during pancreaticoduodenectomy for pancreatic adenocarcinoma: patency rates and outcomes associated with thrombosis. J Surg Oncol 117(8):1648-1654, 2018. e-Pub 2018. PMID: 29723419.
206. Cloyd JM, Omichi K, Mizuno T, Kawaguchi Y, Tzeng CW, Conrad C, Chun YS, Aloia TA, Katz MHG, Lee JE, Halperin D, Yao J, Vauthey JN, Dasari A. Preoperative fluorouracil, doxorubicin and streptozocin for the treatment of pancreatic neuroendocrine liver metastases. Ann Surg Oncol 25(6):1709-1715, 2018. e-Pub 2018. PMID: 29626307.
207. Okuno M, Goumard C, Mizuno T, Kopetz S, Omichi K, Tzeng CW, Chun YS, Lee JE, Vauthey JN, Conrad C. Prognostic impact of perihepatic lymph node metastases in patients with resectable colorectal liver metastases. Br J Surg 105(9):1200-1209, 2018. e-Pub 2018. PMID: 29664996.
208. Goumard C, Ogiso S, Okuno M, Fleming JB, Kim M, Tzeng CW, Vauthey JN, Lee JE, Conrad C. Tips and tricks of splenic vessel preservation during laparoscopic distal pancreatectomy. Surg Endosc 32(4):10.1007/s00464-017-5744-1, 2018. e-Pub 2017. PMID: 28733741.
209. Amer AM, Zaid M, Chaudhury B, Elganainy D, Lee Y, Wilke CT, Cloyd J, Wang H, Maitra A, Wolff RA, Varadhachary G, Overman MJ, Lee JE, Fleming JB, Tzeng CW, Katz MH, Holliday EB, Krishnan S, Minsky BD, Herman JM, Taniguchi CM, Das P, Crane CH, Le O, Bhosale P, Tamm EP, Koay EJ. Imaging-based biomarkers: Changes in the tumor interface of pancreatic ductal adenocarcinoma on computed tomography scans indicate response to cytotoxic therapy. Cancer 124(8):1701-1709, 2018. e-Pub 2018. PMID: 29370450.
210. Patel SH, Kim BJ, Tzeng CW, Chun YS, Conrad C, Vauthey JN, Aloia TA. Reduction of cardiopulmonary/renal complications with serum BNP-guided volume status management in posthepatectomy patients. J Gastrointest Surg 22(3):467-476, 2018. e-Pub 2017. PMID: 29234998.
211. Vega EA, Vinuela E, Yamashita S, Sanhueza M, Cavada G, Diaz C, Aloia TA, Chun YS, Tzeng CWD, Okuno M, Goumard C, Vauthey JN, Lee JE, Conrad C. Extended lymphadenectomy is required for incidental gallbladder cancer independent of cystic duct lymph node status. J Gastrointest Surg 22(2):43-51, 2018. PMID: None.
212. Mizuno T, Cloyd J, Omichi K, Chun YS, Kopetz SE, Maru D, Conrad C, Tzeng CWD, Wei SH, Aloia TA, Vauthey JN. SMAD4 gene mutation predicts poor prognosis in patients undergoing resection for colorectal liver metastases. Eur J Surg Oncol 44(5):684-692, 2018. e-Pub 2018. PMID: None.
213. Omichi K, Yamashita S, Cloyd JM, Shindoh J, Mizuno T, Chun YS, Conrad C, Aloia TA, Vauthey JN, Tzeng CWD. Portal vein embolization reduces postoperative hepatic insufficiency associated with post-chemotherapy hepatic atrophy. J Gastrointest Surg 22(1):60--67, 2018. PMID: None.
214. Kutlu OC, Lee JE, Katz MH, Tzeng CW, Wolff RA, Varadhachary GR, Vauthey JN, Fleming JB, Conrad C. Open pancreaticoduodenectomy case volume predicts outcome of laparoscopic approach: a population-based analysis. Ann Surg 267(3):552-560, 2018. PMID: 28045744.
215. Mizuno T, Cloyd JM, Omichi K, Chun YS, Conrad C, Tzeng CWD, Wei SH, Aloia TA, Vauthey JN. Two-stage hepatectomy vs one-stage major hepatectomy with contralateral resection or ablation for advanced bilobar colorectal liver metastases. J Am Coll Surg 226(5):825-834, 2018. e-Pub 2018. PMID: 29454099.
216. Goumard C, Marcal LP, Wang WL, Somaiah N, Okuno M, Roland CL, Tzeng CW, Chun YS, Feig BW, Vauthey JN, Conrad C. Long-term survival according to histology and radiologic response to preoperative chemotherapy in 126 patients undergoing resection of non-GIST sarcoma liver metastases. Ann Surg Oncol 25(1):107-116, 2018. e-Pub 2017. PMID: 29116489.
217. Omichi K, Shindoh J, Cloyd JM, Mizuno T, Chun YS, Conrad C, Aloia TA, Tzeng CW, Vauthey JN. Liver resection is justified for patients with bilateral multiple colorectal liver metastases: A propensity-score-matched analysis. Eur J Surg Oncol 44(1):122-129, 2018. e-Pub 2017. PMID: 29208318.
218. Yamashita S, Overman MJ, Wang H, Zhao J, Okuno M, Goumard C, Tzeng CW, Kim M, Fleming JB, Vauthey JN, Katz MH, Lee JE, Conrad C. Pathologic response to preoperative therapy as a novel prognosticator for ampullary and duodenal adenocarcinoma. Ann Surg Oncol 24(13):3954-3963, 2017. e-Pub 2017. PMID: 28980211.
219. Cloyd JM, Wang H, Egger ME, Tzeng CW, Prakash LR, Maitra A, Varadhachary GR, Shroff R, Javle M, Fogelman D, Wolff RA, Overman MJ, Koay EJ, Das P, Herman JM, Kim MP, Vauthey JN, Aloia TA, Fleming JB, Lee JE, Katz MHG. Association of clinical factors with a major pathologic response following preoperative therapy for pancreatic ductal adenocarcinoma. JAMA Surg 152(11):1048-1056, 2017. PMID: 28700784.
220. Omichi K, Mizuno T, Okuno M, Tzeng CW, Conrad C, Chun YS, Aloia TA, Vauthey JN. Long term outcome after resection of liver metastases from squamous cell carcinoma. Eur J Surg Oncol 43(11):2129-2134, 2017. e-Pub 2017. PMID: 28958732.
221. Kim BJ, Day RW, Davis CH, Narula N, Kroll MH, Tzeng CWD, Aloia TA. Extended pharmacologic thromboprophylaxis in oncologic liver surgery is safe and effective. J Thromb Haemost 15(11):2158-2164, 2017. e-Pub 2017. PMID: 28846822.
222. Omichi K, Cloyd JM, Yamashita S, Tzeng CW, Conrad C, Chun YS, Aloia TA, Vauthey JN. Neutrophil-to-lymphocyte ratio predicts prognosis after neoadjuvant chemotherapy and resection of intrahepatic cholangiocarcinoma. Surgery 162(4):752-765, 2017. e-Pub 2017. PMID: 28688518.
223. Okuno M, Goumard C, Mizuno T, Omichi K, Tzeng CW, Chun YS, Aloia TA, Fleming JB, Lee JE, Vauthey JN, Conrad C. Operative and short-term oncologic outcomes of laparoscopic versus open liver resection for colorectal liver metastases located in the posterosuperior liver: a propensity score matching analysis. Surg Endosc 32(4):1776-1786, 2017. e-Pub 2017. PMID: 28917012.
224. Vega EA, Yamashita S, Chun YS, Kim M, Fleming JB, Katz MH, Tzeng CW, Raghav KP, Vauthey JN, Lee JE, Conrad C. Effective laparoscopic management lymph node dissection for gallbladder cancer. Ann Surg Oncol 24(7):1852, 2017. e-Pub 2017. PMID: 28168387.
225. Le AT, Huang B, Hnoosh D, Saeed H, Dineen SP, Hosein PJ, Durbin EB, Kudrimoti M, McGrath PC, Tzeng CW. Effect of complications on oncologic outcomes after pancreaticoduodenectomy for pancreatic cancer. J Surg Res 214:1-8, 2017. e-Pub 2017. PMID: 28624029.
226. Abbott DE, Tzeng CW, McMillan MT, Callery MP, Kent TS, Christein JD, Behrman SW, Schauer DP, Hanseman DJ, Eckman MH, Vollmer CM. Pancreas fistula risk prediction: implications for hospital costs and payments. HPB (Oxford) 19(2):154-161, 2017. e-Pub 2016. PMID: 27884544.
227. Le AT, Harris JW, Maynard E, Dineen SP, Tzeng CWD. Thromboelastography demonstrates perioperative hypercoagulability in hepato-pancreato-biliary patients and supports routine administration of preoperative and early postoperative venous thromboembolism chemoprophylaxis. HPB 19(2):154-161, 2017. PMID: None.
228. Okuno M, Gourmard C, Mizuno T, Omichi K, Tzeng CW, Chun YS, Lee JE, Vauthey JN, Conrad C. Pathological diaphragmatic invasion by colorectal liver metastases is associated with RAS mutation, peritoneal recurrence and worse survival. HPB (Oxford) 20(1):57-63, 2017. e-Pub 2017. PMID: None.
229. Frohman HA, Martin JT, Le AT, Dineen S, Tzeng CWD. Failure to operate on resectable gastric cancer: implications for policy changes and regionalization. J Surg Res 214:1-8, 2017. PMID: None.
230. Cloyd JM, Nogueras GM, Prakash LR, Petel MQB, Parker NH, Ngo-Huang AT, Fogelman D, Denbo JW, Garg N, Kim MP, Lee JE, Tzeng CWD, Fleming JB, Katz MHG. Anthropometric changes in patients with pancreatic cancer undergoing preoperative therapy and pancreatoduodenectomy. J Gastrointest Surg 22(4):703-712, 2017. PMID: None.
231. Kim BJ, Tzeng CWD, Cooper AB, Vauthey JN, Aloia TA. Borderline operability in hepatectomy patients is associated with higher rates of failure to rescue after severe complications. J Surg Oncol 115(3):337-343, 2017. PMID: None.
232. DeMasi J, Edwards JM, Shahidain S, Desimone P, Tzeng CW, Hosein P, Lowell A, Kudrimoti MR. Superior Outcomes With Gemcitabine-Based Systemic and Concurrent Administration With Radiation Therapy in Inoperable or Unresectable Cholangiocarcinomas. Int J Radiat Oncol Biol Phys 96(2S):E207-E208, 2016. PMID: 27674063.
233. Saeed H, Hnoosh D, Huang B, Durbin EB, McGrath PC, Desimone P, Maynard E, Anthony LB, Dineen SP, Hosein PJ, Tzeng CW. Defining the optimal timing of adjuvant therapy for resected pancreatic adenocarcinoma: A statewide cancer registry analysis. J Surg Oncol 114(4):451-5, 2016. e-Pub 2016. PMID: 27238300.
234. Vilchez V, Turcios L, Zaytseva Y, Stewart R, Lee EY, Maynard E, Shah MB, Daily MF, Tzeng CW, Davenport D, Castellanos AL, Krohmer S, Hosein PJ, Evers BM, Gedaly R. Cancer stem cell marker expression alone and in combination with microvascular invasion predicts poor prognosis in patients undergoing transplantation for hepatocellular carcinoma. Am J Surg 212(2):238-45, 2016. e-Pub 2016. PMID: 27033253.
235. Zimmitti G, Soliz J, Aloia TA, Gottumukkala V, Cata JP, Tzeng CW, Vauthey JN. Positive impact of epidural analgesia on oncologic outcomes in patients undergoing resection of colorectal liver metastases. Ann Surg Oncol 23(3):1003-11, 2016. e-Pub 2015. PMID: 26511261.
236. Zwischenberger BA, Tzeng CW, Ward ND, Zwischenberger JB, Martin JT. Venous thromboembolism prophylaxis for esophagectomy: a survey of practice patterns among thoracic surgeons. Ann Thorac Surg 101(2):489-94, 2016. e-Pub 2015. PMID: 26409709.
237. Vilchez V, Shah MB, Daily MF, Pena L, Tzeng CW, Davenport D, Hosein PJ, Gedaly R, Maynard E. Long-term outcome of patients undergoing liver transplantation for mixed hepatocellular carcinoma and cholangiocarcinoma: an analysis of the UNOS database. HPB (Oxford) 18(1):29-34, 2016. e-Pub 2016. PMID: 26776848.
238. Labori KJ, Katz MH, Tzeng CW, Bjørnbeth BA, Cvancarova M, Edwin B, Kure EH, Eide TJ, Dueland S, Buanes T, Gladhaug IP. Impact of early disease progression and surgical complications on adjuvant chemotherapy completion rates and survival in patients undergoing the surgery first approach for resectable pancreatic ductal adenocarcinoma - A population-based cohort study. Acta Oncol 55(3):265-77, 2016. e-Pub 2015. PMID: 26213211.
239. Roland CL, Katz MH, Tzeng CW, Lin H, Varadhachary GR, Shroff R, Javle M, Fogelman D, Wolff RA, Vauthey JN, Crane CH, Lee JE, Fleming JB. The addition of postoperative chemotherapy is associated with improved survival in patients with pancreatic cancer treated with preoperative therapy. Ann Surg Oncol 22 Suppl 3:S1221-8, 2015. e-Pub 2015. PMID: 26350371.
240. Khushman M, Dempsey N, Maldonado JC, Loaiza-Bonilla A, Velez M, Carcas L, Dammrich D, Hurtado-Cordovi J, Parajuli R, Pollack T, Harwood AP, Macintyre J, Tzeng CW, Merchan JR, Restrepo MH, Akunyili II, Ribeiro A, Narayanan G, Portelance L, Sleeman D, Levi JU, Lima CM, Hosein PJ. Full dose neoadjuvant FOLFIRINOX is associated with prolonged survival in patients with locally advanced pancreatic adenocarcinoma. Pancreatology 15(6):667-73, 2015. e-Pub 2015. PMID: 26412296.
241. Martin JT, Mahan AL, Ferraris VA, Saha SP, Mullett TW, Zwischenberger JB, Tzeng CW. Identifying Esophagectomy Patients at Risk for Predischarge Versus Postdischarge Venous Thromboembolism. Ann Thorac Surg 100(3):932-8; discussion 938, 2015. e-Pub 2015. PMID: 26190389.
242. Harris JW, Martin JT, Maynard EC, McGrath PC, Tzeng CW. Increased morbidity and mortality of a concomitant colectomy during a pancreaticoduodenectomy: an NSQIP propensity-score matched analysis. HPB (Oxford) 17(9):846-54, 2015. e-Pub 2015. PMID: 26223475.
243. Martin JT, Mahan A, Zwischenberger JB, McGrath PC, Tzeng CW. Should gastric cardia cancers be treated with esophagectomy or total gastrectomy? A comprehensive analysis of 4,996 NSQIP/SEER patients. J Am Coll Surg 220(4):510-20, 2015. e-Pub 2014. PMID: 25667138.
244. Kim S, Maynard EC, Shah MB, Daily MF, Tzeng CW, Davenport DL, Gedaly R. Risk factors for 30-day readmissions after hepatectomy: analysis of 2444 patients from the ACS-NSQIP database. J Gastrointest Surg 19(2):266-71, 2015. e-Pub 2014. PMID: 25451735.
245. Hyngstrom JR, Tzeng CW, Beddar S, Das P, Krishnan S, Delclos ME, Crane CH, Chang GJ, You YN, Feig BW, Skibber JM, Rodriguez-Bigas MA. Intraoperative radiation therapy for locally advanced primary and recurrent colorectal cancer: ten-year institutional experience. J Surg Oncol 109(7):652-8, 2014. e-Pub 2014. PMID: 24510523.
246. Tzeng CW, Cooper AB, Vauthey JN, Curley SA, Aloia TA. Predictors of morbidity and mortality after hepatectomy in elderly patients: analysis of 7621 NSQIP patients. HPB (Oxford) 16(5):459-68, 2014. e-Pub 2013. PMID: 24033514.
247. Tzeng CW, Balachandran A, Ahmad M, Lee JE, Krishnan S, Wang H, Crane CH, Wolff RA, Varadhachary GR, Pisters PW, Aloia TA, Vauthey JN, Fleming JB, Katz MH. Serum carbohydrate antigen 19-9 represents a marker of response to neoadjuvant therapy in patients with borderline resectable pancreatic cancer. HPB (Oxford) 16(5):430-8, 2014. e-Pub 2013. PMID: 23991810.
248. Tzeng CW, Katz MH, Lee JE, Fleming JB, Pisters PW, Vauthey JN, Aloia TA. Predicting the risks of venous thromboembolism versus post-pancreatectomy haemorrhage: analysis of 13,771 NSQIP patients. HPB (Oxford) 16(4):373-83, 2014. e-Pub 2013. PMID: 23869628.
249. Cho SW, Tzeng CW, Johnston WC, Cassera MA, Newell PH, Hammill CW, Wolf RF, Aloia TA, Hansen PD. Neoadjuvant radiation therapy and its impact on complications after pancreaticoduodenectomy for pancreatic cancer: analysis of the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP). HPB (Oxford) 16(4):350-6, 2014. e-Pub 2013. PMID: 24112766.
250. Roses RE, Tzeng CW, Ross MI, Fournier KF, Abbott DE, You YN. The palliative index: predicting outcomes of emergent surgery in patients with cancer. J Palliat Med 17(1):37-42, 2014. PMID: 24410420.
251. Tzeng CW, Tran Cao HS, Lee JE, Pisters PW, Varadhachary GR, Wolff RA, Abbruzzese JL, Crane CH, Evans DB, Wang H, Abbott DE, Vauthey JN, Aloia TA, Fleming JB, Katz MH. Treatment sequencing for resectable pancreatic cancer: influence of early metastases and surgical complications on multimodality therapy completion and survival. J Gastrointest Surg 18(1):16-24; discussion 24-5, 2014. e-Pub 2013. PMID: 24241967.
252. Shindoh J, Tzeng CW, Aloia TA, Curley SA, Huang SY, Mahvash A, Gupta S, Wallace MJ, Vauthey JN. Safety and efficacy of portal vein embolization before planned major or extended hepatectomy: an institutional experience of 358 patients. J Gastrointest Surg 18(1):45-51, 2014. e-Pub 2013. PMID: 24129824.
253. Tzeng CW, Katz MH, Fleming JB, Lee JE, Pisters PW, Holmes HM, Varadhachary GR, Wolff RA, Abbruzzese JL, Vauthey JN, Aloia TA. Morbidity and mortality after pancreaticoduodenectomy in patients with borderline resectable type C clinical classification. J Gastrointest Surg 18(1):146-55; discussion 155-6, 2014. e-Pub 2013. PMID: 24129825.
254. Zimmitti G, Vauthey JN, Shindoh J, Tzeng CW, Roses RE, Ribero D, Capussotti L, Giuliante F, Nuzzo G, Aloia TA. Systematic use of an intraoperative air leak test at the time of major liver resection reduces the rate of postoperative biliary complications. J Am Coll Surg 217(6):1028-37, 2013. PMID: 24246619.
255. Lee S, Reha JL, Tzeng CW, Massarweh NN, Chang GJ, Hetz SP, Fleming JB, Lee JE, Katz MH. Race does not impact pancreatic cancer treatment and survival in an equal access federal health care system. Ann Surg Oncol 20(13):4073-9, 2013. e-Pub 2013. PMID: 24002535.
256. Shindoh J, Tzeng CW, Aloia TA, Curley SA, Zimmitti G, Wei SH, Huang SY, Gupta S, Wallace MJ, Vauthey JN. Portal vein embolization improves rate of resection of extensive colorectal liver metastases without worsening survival. Br J Surg 100(13):1777-83, 2013. PMID: 24227364.
257. Abbott DE, Tzeng CW, Merkow RP, Cantor SB, Chang GJ, Katz MH, Bentrem DJ, Bilimoria KY, Crane CH, Varadhachary GR, Abbruzzese JL, Wolff RA, Lee JE, Evans DB, Fleming JB. The cost-effectiveness of neoadjuvant chemoradiation is superior to a surgery-first approach in the treatment of pancreatic head adenocarcinoma. Ann Surg Oncol 20 Suppl 3:S500-8, 2013. e-Pub 2013. PMID: 23397153.
258. Tzeng CW, Curley SA, Vauthey JN, Aloia TA. Distinct predictors of pre- versus post-discharge venous thromboembolism after hepatectomy: analysis of 7621 NSQIP patients. HPB (Oxford) 15(10):773-80, 2013. e-Pub 2013. PMID: 23869577.
259. Shindoh J, Tzeng CW, Aloia TA, Curley SA, Zimmitti G, Wei SH, Huang SY, Mahvash A, Gupta S, Wallace MJ, Vauthey JN. Optimal future liver remnant in patients treated with extensive preoperative chemotherapy for colorectal liver metastases. Ann Surg Oncol 20(8):2493-500, 2013. e-Pub 2013. PMID: 23377564.
260. Tzeng CW, Abbott DE, Cantor SB, Fleming JB, Lee JE, Pisters PW, Varadhachary GR, Abbruzzese JL, Wolff RA, Ahmad SA, Katz MH. Frequency and intensity of postoperative surveillance after curative treatment of pancreatic cancer: a cost-effectiveness analysis. Ann Surg Oncol 20(7):2197-203, 2013. e-Pub 2013. PMID: 23408126.
261. Tzeng CW, Aloia TA, Vauthey JN, Chang GJ, Ellis LM, Feig BW, Curley SA, Skibber JM, Abdalla EK, You YN, Rodriguez-Bigas MA. Morbidity of staged proctectomy after hepatectomy for colorectal cancer: a matched case-control analysis. Ann Surg Oncol 20(2):482-90, 2013. e-Pub 2012. PMID: 22932858.
262. Tzeng CW, Katz MH, Fleming JB, Pisters PW, Lee JE, Abdalla EK, Curley SA, Vauthey JN, Aloia TA. Risk of venous thromboembolism outweighs post-hepatectomy bleeding complications: analysis of 5651 National Surgical Quality Improvement Program patients. HPB (Oxford) 14(8):506-13, 2012. e-Pub 2012. PMID: 22762398.
263. Tzeng CW, Fleming JB, Lee JE, Xiao L, Pisters PW, Vauthey JN, Abdalla EK, Wolff RA, Varadhachary GR, Fogelman DR, Crane CH, Balachandran A, Katz MH. Defined clinical classifications are associated with outcome of patients with anatomically resectable pancreatic adenocarcinoma treated with neoadjuvant therapy. Ann Surg Oncol 19(6):2045-53, 2012. e-Pub 2012. PMID: 22258816.
264. Tzeng CW, Fleming JB, Lee JE, Wang X, Pisters PW, Vauthey JN, Varadhachary G, Wolff RA, Katz MH. Yield of clinical and radiographic surveillance in patients with resected pancreatic adenocarcinoma following multimodal therapy. HPB (Oxford) 14(6):365-72, 2012. e-Pub 2012. PMID: 22568412.
265. Liles JS, Arnoletti JP, Tzeng CW, Howard JH, Kossenkov AV, Kulesza P, Heslin MJ, Frolov A. ErbB3 expression promotes tumorigenesis in pancreatic adenocarcinoma. Cancer Biol Ther 10(6):555-63, 2010. e-Pub 2010. PMID: 20647770.
266. Frolov A, Liles JS, Kossenkov AV, Tzeng CW, Jhala N, Kulesza P, Varadarajulu S, Eloubeidi M, Heslin MJ, Arnoletti JP. Epidermal growth factor receptor (EGFR) intron 1 polymorphism and clinical outcome in pancreatic adenocarcinoma. Am J Surg 200(3):398-405, 2010. e-Pub 2010. PMID: 20409526.
267. Howard JH, Frolov A, Tzeng CW, Stewart A, Midzak A, Majmundar A, Godwin A, Heslin M, Bellacosa A, Arnoletti JP. Epigenetic downregulation of the DNA repair gene MED1/MBD4 in colorectal and ovarian cancer. Cancer Biol Ther 8(1):94-100, 2009. e-Pub 2009. PMID: 19127118.
268. Howard JH, Tzeng CW, Smith JK, Eckhoff DE, Bynon JS, Wang T, Arnoletti JP, Heslin MJ. Radiofrequency ablation for unresectable tumors of the liver. Am Surg 74(7):594-600; discussion 600-1, 2008. PMID: 18646476.
269. Tzeng CW, Frolov A, Frolova N, Jhala NC, Howard JH, Vickers SM, Buchsbaum DJ, Heslin MJ, Arnoletti JP. EGFR genomic gain and aberrant pathway signaling in pancreatic cancer patients. J Surg Res 143(1):20-6, 2007. PMID: 17950068.
270. Tzeng CW, Frolov A, Frolova N, Jhala NC, Howard JH, Vickers SM, Buchsbaum DJ, Heslin MJ, Arnoletti JP. Pancreatic cancer epidermal growth factor receptor (EGFR) intron 1 polymorphism influences postoperative patient survival and in vitro erlotinib response. Ann Surg Oncol 14(7):2150-8, 2007. e-Pub 2007. PMID: 17453292.
271. Tzeng CW, Frolov A, Frolova N, Jhala NC, Howard JH, Buchsbaum DJ, Vickers SM, Heslin MJ, Arnoletti JP. Epidermal growth factor receptor (EGFR) is highly conserved in pancreatic cancer. Surgery 141(4):464-9, 2007. e-Pub 2007. PMID: 17383523.
272. Frolov A, Schuller K, Tzeng CW, Cannon EE, Ku BC, Howard JH, Vickers SM, Heslin MJ, Buchsbaum DJ, Arnoletti JP. ErbB3 expression and dimerization with EGFR influence pancreatic cancer cell sensitivity to erlotinib. Cancer Biol Ther 6(4):548-54, 2007. PMID: 17457047.
273. Tzeng CW, Fiveash JB, Popple RA, Arnoletti JP, Russo SM, Urist MM, Bland KI, Heslin MJ. Preoperative radiation therapy with selective dose escalation to the margin at risk for retroperitoneal sarcoma. Cancer 107(2):371-9, 2006. PMID: 16752414.
274. Boyev A, Prakash LR, Chiang YJ, Childers CP, Jain AJ, Newhook TE, Bruno ML, Arvide EM, Dewhurst WL, Kim MP, Ikoma N, Lee JE, Snyder RA, Katz MHG, Tzeng, CWD, Maxwell JE. Postoperative opioid use is associated with increased rates of Grade B/C pancreatic fistula after distal pancreatectomy. J Gastrointest Surg. PMID: None.

Invited Articles

1. Hirata Y, Tzeng CD, Ikoma N. ASO Author Reflections: Value of robotic surgery in the era of opioid crisis. Ann Surg Oncol 29(9):5871-5872, 2022. e-Pub 2022. PMID: 35538175.
2. White MG, Tzeng CD. ASO Author Reflections: Potential Role of Circulating Biomarkers in Resected Pancreatic Adenocarcinoma. Ann Surg Oncol 28(8):10.1245/s10434-021-09611-w, 2021. e-Pub 2021. PMID: 33507452.
3. Tzeng CD. Synchronous colorectal liver metastases with asymptomatic primary tumors: An individualized sequencing approach remains ideal. Surgery. e-Pub 2021. PMID: 33952392.
4. Kawaguchi Y, Newhook TE, Fuks D, Cao HST, Tzeng CD, Chun YS, Aloia TA, Gayet B, Vauthey JN. Comment on "Stratification of major hepatectomies according to their outcome analysis of 2212 consecutive open resections in patients without cirrhosis". Ann Surg. e-Pub 2021. PMID: 33914451.
5. Newhook TE, Tzeng CWD. Author's Reflections: Tumor biology and safe surgery remain major determinants of survival after resection of pancreatic adenocarcinoma. Ann Surg Oncol 28:1570-1571, 2020. PMID: None.
6. Roland CL, Grubbs EG, Katz MHG, Teshome M, Hunt KK, Tzeng CW. Clinical trials-Designing, implementing, and collaborating. J Surg Oncol 122(1):25-28. e-Pub 2020. PMID: 32149390.
7. Lillemoe HA, Tzeng CD. ASO Author Reflections: Opioid Prescribing in Surgical Oncology-Institutional Opportunities for Educational Interventions. Ann Surg Oncol 26(Suppl 3):731-732, 2019. e-Pub 2019. PMID: 31529310.
8. Newhook TE, Tzeng CD. ASO Author Reflections: Opportunities for Reducing Initial Opioid Exposure in Cancer Surgery Patients. Ann Surg Oncol 26(Suppl 3):749-750, 2019. e-Pub 2019. PMID: 31559543.
9. Melstrom LG, Tzeng CD. Metastatic colorectal cancer: The reality of the present and the optimism of the future. J Surg Oncol 119(5):547-548, 2019. e-Pub 2019. PMID: 30806484.
10. Le AT, Tzeng CW. Does finding early recurrence improve outcomes, and at what cost?. J Surg Oncol 114(3):329-35, 2016. e-Pub 2016. PMID: 27393742.
11. Torzilli G, Nagino M, Tzeng CW, Kingham TP, Alatise OI, Ayandipo OO, Yamashita S, Arrington AK, Kim J, Chun YS, Vauthey JN. SSAT State-of-the-Art Conference: New Frontiers in Liver Surgery. J Gastrointest Surg 21(1):175-175, 2016. e-Pub 2016. PMID: None.
12. Cooper AB, Tzeng CW, Katz MH. Treatment of borderline resectable pancreatic cancer. Curr Treat Options Oncol 14(3):293-310, 2013. PMID: 23793524.
13. Tzeng CW, Aloia TA. Colorectal liver metastases. J Gastrointest Surg 17(1):195-201; quiz p.201-2, 2013. e-Pub 2012. PMID: 23054896.
14. Liles JS, Tzeng CW, Short JJ, Kulesza P, Heslin MJ. Retroperitoneal and intra-abdominal sarcoma. Curr Probl Surg 46(6):445-503, 2009. PMID: 19414097.
15. Tzeng CW, Smith JK, Heslin MJ. Soft tissue sarcoma: preoperative and postoperative imaging for staging. Surg Oncol Clin N Am 16(2):389-402, 2007. PMID: 17560519.
16. Tzeng CW, Fiveash JB, Heslin MJ. Radiation therapy for retroperitoneal sarcoma. Expert Rev Anticancer Ther 6(8):1251-60, 2006. PMID: 16925491.

Other Articles

1. Torres MB, Maxwell JE, Snyder RA, Cao HST, Kim MP, Tzeng CD, Lee JE, Katz MHG, Ikoma N Total Venous Control and Vein-to-the-Right Superior Mesenteric Artery Approach in Robotic Pancreatoduodenectomy. Ann Surg Oncol 31(13):8721-8722, 2024. PMID: 39284994.
2. Fields BC, Tzeng CD Locally Advanced Pancreas Cancer, Is There a Role for Surgery?. Surg Clin North Am 104(5):1017-1030, 2024. PMID: 39237161.
3. Tzeng CD The Impact of Intraoperative Anesthesiology Provider Handovers on Postoperative Complications After Hepatopancreatobiliary (HPB) Surgery. Journal of Surgical Oncology None(None):None, 2024. PMID: None.
4. DiPeri TP, Newhook TE, Day RW, Chiang YJ, Dewhurst WL, Arvide EM, Bruno ML, Scally CP, Roland CL, Katz MHG, Vauthey JN, Chang GJ, Badgwell BD, Perrier ND, Grubbs EG, Lee JE, Tzeng CD, Consortium P A prospective feasibility study evaluating the 5x-multiplier to standardize discharge prescriptions in cancer surgery patients. Surg Open Sci 9(9):51–57, 2022. PMID: 35663797.
5. Bagley AF, Ludmir EB, Maitra A, Minsky BD, Li Smith G, Das P, Koong AC, Holliday EB, Taniguchi CM, Katz MHG, Tamm EP, Wolff RA, Overman MJ, Patel S, Kim MP, Tzeng CD, Ikoma N, Bhutani MS, Koay EJ NBTXR3, a first-in-class radioenhancer for pancreatic ductal adenocarcinoma: Report of first patient experience. Clin Transl Radiat Oncol 33:66-69, 2022. PMID: 35097226.
6. Gaskill CE, Maxwell J, Ikoma N, Kim MP, Tzeng CW, Lee JE, Katz MHG History of preoperative therapy for pancreatic cancer and the MD Anderson experience. J Surg Oncol 123(6):1414-1422, 2021. PMID: 33831256.
7. Coronel M, Lanke G, Cambell D, Coronel E, Tzeng CD, Foo W, Lee JH Performing endoscopic retrograde cholagiopancreatpgraphy and endoscopic ultrasound for management of malignant bile duct obstruction in a patient with a situs inversus totalis. ACG Case Rep J 7(12):e00483, 2020. PMID: 33324708.
8. Hance JM, Harris JW, Neltner J, Vilchez V, Tzeng CW, Maynard E, Gedaly R, Shah MB Hepatobiliary mucinous cystadenoma resulting in biliary obstruction. Am Surg 81(6):E238-9, 2015. PMID: 26031251.

Editorials

1. Ayabe RI, Beaty K, Newhook TE, Cao HST, Tzeng CD, Helmink BA, Uppal A, Vauthey JN, Fournier KF, White MG. Incomplete Cytoreduction and Need for Major Hepatectomy Predict Shorter Survival in Patients Undergoing Combined Cytoreductive Surgery and Hepatectomy for Metastatic Colorectal Cancer. Ann Surg Oncol 31(10):6366-6368, 2024. PMID: 38971956.
2. Cass SH, Tzeng CD, Prakash LR, Maxwell J, Snyder RA, Kim MP, Huey RW, Smaglo BG, Pant S, Koay EJ, Wolff RA, Lee JE, Katz MHG, Ikoma N. Trends Over Time in Recurrence Patterns and Survival Outcomes after Neoadjuvant Therapy and Surgery for Pancreatic Cancer. Ann Surg. PMID: 38506042.
3. Kawaguchi Y, Tzeng CD, Hasegawa K, Kokudo N, Vauthey JN. Author response to: Comment on: Performance of a modified three-level classification in stratifying open liver resection procedures in terms of complexity and postoperative morbidity. Br J Surg 107(4):469, 2020. PMID: 32129492.
4. Lillemoe HA, Tzeng CWD. ASO Author Reflections: Opioid Prescribing in Surgical Oncology—Institutional Opportunities for Educational Interventions. Ann Surg Oncol, 2019. PMID: None.
5. Tzeng CW, Vauthey JN. Evaluation of new classifications for liver surgery: can anatomic granularity predict both complexity and outcomes of hepatic resection?. Ann Surg 267(1):24-25, 2018. PMID: None.
6. Tzeng CW, Vauthey JN. Postoperative complications and oncologic outcomes after resection of colorectal liver metastases: the importance of staying on track. Ann Surg Oncol 20(8):2457-9, 2013. PMID: 23579874.

Abstracts

1. Martin AN, Newhook TE, Arvide M, Dewhurst W, Jin A, Tran Cao HS, Chun YS, Vauthey JN, Tzeng CWD. Prospective cohort study of compliance with risk-stratified post-hepatectomy pathways. 38th Annual SSAT Residents and Fellows Research Conference, 2023. PMID: None.
2. Vega EA, Newhook TE, Ruzzenente A, Okuno M, De Bellis M, Panettieri E, De Rose AM, Uemoto S, Chun YS, Tran Cao HS, Tzeng CWD, de Aretxabala X, Seo S, Giuliante F, Guglielmi A, Vinuela E, Vauthey JN. Benchmark analysis: multi-institutional cooperative cohort for gallbladder cancer surgery. SSAT Abstract -Plenary Session: Hepatobiliary & Pancreas II, 2022. PMID: None.
3. Witt RG, Prakash LR, Arvide EM, Newhook TE, Bruno ML, Dewhurst WL, Maxwell JE, Lee JE, Kim MP, Katz MHG, Tzeng CWD, Ikoma N. Comparative analysis of opioid use between robotic and open pancreaticoduodenectomy. SSO ePoster, 2022. PMID: None.
4. Martin AN, Swords DS, Newhook TE, Tran Cao HS, Grubbs EG, Ledet CR, Vauthey JN, Lee JE, Katz MH, Tzeng CWD. Post-hepatectomy liver failure and chronic kidney disease: time to retire the African American GFR corrector?. Quickshot Presentation: 17th Annual Academic Surgical Congress, 2022. PMID: None.
5. DiPeri TP, Newhook TE, Tran Cao HS, Ikoma N Dewhurst WL, Arvide EM, Bruno ML, Katz MHG, Vauthey JN, Lee JE, Tzeng CWD. Opioid discharge prescriptions after inpatient surgery: risks of rebound refills by length of stay. Oral Presentation:17th Annual Academic Surgical Congress, 2022. PMID: None.
6. Concors SJ, Arvide EM, Prakash LR, Soones TN, Ngo-Huang AT, Nguyen VQ, Newhook TE, Ikoma N, Maxwell JE, Tran Cao HS, Chun YS, Kim M, Lee JE, Vauthey JN, Katz MHG, Tzeng CD. Mitigating serious morbidity for older patients undergoing major pancreatic and hepatobiliary surgery. DDW 2022 Abstract # 3692379, 2022. PMID: None.
7. DiPeri TP, Newhook TE, Tzeng CWD, Chun YS, Lee SS, Javle M, Vauthey JN, Tran Cao HS. Prognostic significance of serum CA 19-9 response and dynamics in patients with intrahepatic cholangiocarcinoma undergoing surgical resection. Poster presentation ASCO GI, 2022. PMID: None.
8. Martin AN, Bradford BJ, Newhook TE, Arvide EM, Dewhurst WL, Kawaguchi Y, Tran Cao HS, Chun YS, Katz MHG, Vauthey JN, Tzeng CWD. Individual Components of Post-Hepatectomy Care Pathways Have Differential Impacts on Length of Stay. IHPBA 2022 – ePoster Presentation acceptance (EP01C-043, 2021. PMID: None.
9. DiPeri, Newhook TE, Arvide EM, Dewhurst WL, Bruno ML, Martin AN, Kim BJ, Chun YS, Tran Cao HS, Lee JE, Vauthey JN, Tzeng CWD. Prospective implementation of standardized post-hepatectomy care pathways to reduce opioid prescription volumes after inpatient surgery. Oral Presentation: The Western Surgical Association, 2021. PMID: None.
10. Witt R, Newhook TE, Bruno ML, Arvide EM, Dewhurst WL, Ikoma N, Maxwell JE, Kim MP, Lee JE, Katz MHG, Tzeng CWD. Impact of First-Day Intravenous Patient Controlled Analgesia Use on Total Inpatient Opioid Use after Pancreatectomy. Society of Asian Academic Surgeons 6th Annual Meeting, 2021. PMID: None.
11. Martin AN, Tzeng CWD, Arvide EM, Skibber JM, Chang GJ, You N, Bednarski BK, Dewhurst WL, Cristo JV, Chun YS, Tran Cao HS, Vauthey JN, Newhook TE. Cumulative operative time and postoperative complication risk in synchronous resections of colorectal liver metastases and primary tumors. ON-DEMAND Oral presentation Annual Meeting AHPBA, 2021. PMID: None.
12. Fujii Y, Tzeng CW, Chiang YI, Halperin DM, Dasari A, Kim MP, Katz MHG, Lee JE, Ikoma N. Survival Impact of Incidence of Lymph Node Metastases and Radical Resection for Duodenal Neuroendocrine Tumors: Analyses of the National Cancer Database 2004-2016. ON-DEMAND Presentation Annual Meeting AHPBA, 2021. PMID: None.
13. Ikoma N, Kim MP, Tran Cao HS, Prakash LP, Maxwell JE, Tzeng CWD, Mansfield PF, Lee JE, Badgwell BD, Katz MHG. Early Experience of a Robotic Foregut Surgery Program at a Cancer Center: Video of Shared Steps in Robotic Pancreatoduodenectomy and Gastrectomy. ON-DEMAND Video Presentation Annual Meeting AHPBA, 2021. PMID: None.
14. Swords D, Prakash LP, Newhook TE, Tran Cao HS, Ikoma N, Maxwell J, Kim M, Lee JE, Katz MHG, Tzeng CWD. Neighborhood-level socioeconomic status and outcomes in patients with localized pancreatic adenocarcinoma treated with first-line FOLFIRINOX. Mini Oral Presentation Annual Meeting AHPBA, 2021. PMID: None.
15. Donovan EC, Prakash LR, Bruno ML, Ikoma N, Vauthey JN, Wei CWD, Katz MHG, Lee JE, Kim MP. Incidence of postoperative complications following pancreatectomy for mucinous cystic lesions versus pancreatic cancer. ON-DEMAND Presentation Annual Meeting AHPBA, 2021. PMID: None.
16. DiPeri TP, Newhook TE, Prakash LR, Ikoma N, Maxwell JE, Kim MP, Lee JE, Katz MHG, Tzeng CWD. Prognostic Significance of Preoperative and Postoperative CA 19-9 Normalization in Pancreatic Adenocarcinoma Treated with Neoadjuvant Therapy or Surgery First. MINI ORAL Presentation Annual Meeting AHPBA, 2021. PMID: None.
17. Martin AN, Arvide EM, Newhook TE, DiBrito SR, Kim B, Dewhurst W, Lee T, Kawaguchi Y, Tran Cao HS, Aloia TA, Chun YS, Katz M, Vauthey JN, Tzeng CWD. Post-hepatectomy pathways: Using inpatient risk-stratification to inform outpatient follow-up. SSAT 2021 - DDW 2021 Abstract # 3519686 Accepted as Poster of Distinction, 2021. PMID: None.
18. Mason MC, Krasnodebski M, Barker CA, Nishioka Y, Kothari AN, Chiang YJ, Newhook TE, Tzeng CD, Chun YS, Aloia TA, Vauthey JN, Tran Cao HS. Outcomes of mixed pathologic response in patients with multiple colorectal liver metastases treated with neoadjuvant chemotherapy and liver resection. SSAT 2021 - DDW 2021, 2021. PMID: None.
19. Paez Arango N, Nishioka Y, Kawaguchi Y, Oppliger Boettcher F, Newhook TE, Chun YS, Aloia TA, Tzeng CWD, Tran Cao H, Lee JE, Vreeland TJ, Vauthey JN. Neither surgical margin status nor somatic mutation predicts local recurrence after R0-intent resection for colorectal liver metastases. DDW 2021 Abstract SSAT Presidential Plenary I, 2021. PMID: None.
20. Newton AD, Newhook TE, Bruno ML, Prakash LR, Chiang YJ, Arango NP, Dewhurst WL, Arvide EM, Ikoma N, Maxwell JE, Kim MP, Lee JE, Katz MHG, Tzeng CWD. Iterative Changes in Risk-Stratified Pancreatectomy Clinical Pathways and Factors Associated with Accelerated Discharge After Pancreaticoduodenectomy. SSAT 2021, 2021. PMID: None.
21. Newton AD, Newhook TE, Prakash LR, Bruno MS, Dewhurst WL, Arvide EM, Ikoma N, Kim MP, Maxwell JE, Lee JE, Katz MHG, Tzeng CWD. Validation of Practice-Specific Drain Fluid Amylase Cutoffs Following Pancreaticoduodenectomy in Risk-Stratified Pancreatectomy Care Pathways. SSAT 2021 - DDW 2021 Abstract # 3523837 quick shot lecture presentation, 2021. PMID: None.
22. Gaskill CE, Kim BJ, Newhook TE, Arvide EM, Dewhurst WL, Phan TL, Cristo J, Tran Cao H, Aloia TA, Chun Y, Vauthey JN, Tzeng CD. Every drop matters: Intraoperative fluids during hepatectomy and postoperative ileus. SSAT 2021, 2021. PMID: None.
23. Swords DS, Newhook TE, Tzeng CWD, Chun YS, Aloia TA, Vauthey JN, Tran Cao HS. Disparities in Use of Surgical Treatments Mediate Half of Socioeconomic Survival Disparities in Stage I-II Hepatocellular Carcinoma. DDW 2021 Abstract # 3520007, 2021. PMID: None.
24. Kim BJ, Gaskill C, Arvide E, Dewhurst WL, Lee T, Kawaguchi Y, Newhook TE, Vauthey JN, Tzeng CD. Utilization of the Kawaguchi-Gayet Complexity classification to stratify hepatectomy patients for distinct enhanced recovery pathways based on anticipated length of stay. IHPBA PL03-033, 2020. PMID: None.
25. Newhook TM, Prakash LR, Bruno ML, Dewhurst WL, Ikoma N, Kim M, Lee JE, Katz MHG, Tzeng CWD. Neoadjuvant treatment sequencing may mitigate the detrimental effects of major complications after resection of pancreatic adenocarcinoma. IHPBA - OP04-13, 2020. PMID: None.
26. Ikoma N, Kim MP, Tzeng CWD, Tran Cao HS, Lee JE, Katz MHG. Surgeon at Work, External retraction techniques for robotic pancreatoduodenectomy. Ann Surg Oncol, 2020. PMID: None.
27. Kim BJ, Lillemoe HA, Newhook TE, Day RW, Dewhurst WL, Arvide E, Katz MH, Aloia TA, Vauthey JN, Lee JE, Tzeng CD. Educating surgical oncology providers on perioperative opioid use: a departmental survey one year after intervention. SSO 2020 - Oral Presentation - March 25-28, 2020, 2020. PMID: None.
28. Newhook T, Griffin JF, Prakash LR, Bruno M, Dewhurst WL, Ikoma N, Kim J, Vauthey JN, Lee JE, Katz JH, Tzeng CW. Neoadjuvant treatment mitigates the survival impact of major complications after resection of pancreatic adenocarcinoma. AHPBA, 2020, 2019. PMID: None.
29. Gaskill C, Kim M, Newhook T, Arvide E, Dewhurst W, Tran Cao H, Chun YS, Aloia TA, Vauthey JN, Tzeng CW. Selective post-hepatectomy surgical drain placement and liver-related complications. AHBPA 2020 - ePoster Display - March 6-8, 2020, 2019. PMID: None.
30. Newhook TE, Griffin JF, Slack RS, Vreeland TJ, Prakash L, Ikoma N, Kim MP, Vauthey JN, Lee JE, Katz MHG, Tzeng CD. Both CA19-9 response trajectory and normalization during neoadjuvant therapy are associated with post-resection prognosis in pancreatic adenocarcinoma patients. AHPBA - Mini Oral Session - March 6, 2020, 2019. PMID: None.
31. Lillemoe HA, Newhook TE, Aloia TA, Grubbs EG, Chang GJ, Katz MHG, Vauthey JN, Lee JE, Tzeng CWD. Perceptions of Opioid Use and Prescribing Habits in Oncologic Surgery: A Survey of the Society of Surgical Oncology Membership. SSO 2020, 2019. PMID: None.
32. Day RW, Newhook TE, Dewhurst M, Arvide M, Bruno M, Kim MP, Tran Cao HS, Ikoma N, Chun YS, Aloia TA, Katz MH, Lee JE, Vauthey JN, Tzeng CW. Patient-specific opioid volume calculations reduce discharge prescriptions after hepato-pancreato-biliary surgery. AHPBA - Presidential Plenary Presentation - March 6, 2020, 2019. PMID: None.
33. Newhook T, Griffin J, Prakash L, Dewhurst W, Bruno M, Ikoma N, Kim M, Vauthey JN, Lee JE, Katz MH, Tzeng CWD. Multimodality therapy may mitigate the survival impact of blood transfusions in pancreatic cancer. Academic Surgical Congress : ASC20201313, 2019. PMID: None.
34. Newhook TE, Vreeland TJ, Dewhurst WL, Arvide M, Bruno ML, Robinson KA, Rajkot N, Lillemow HA, Grubbs EG, Aloia TA, Katz MHG, Vauthey JN, Lee JE, Tzeng CWD. Opioid prescribing practices following major oncologic surgery: a single-center experience. 2019 ACS Quality and Safety Conference, 2019. PMID: None.
35. Newhook T, Tzeng CWD. Clinical factors associated with practice variation in discharge opioid prescriptions after pancreatectomy. 1st place in the Cancer Survivorship Abstract Competition for Trainee Research Day 2019 and finalist in the Clinical Research category for Trainee Research Day 2019, 2019. PMID: None.
36. Vreeland TJ, Simoneau E, Westin S, Mehran R, Dewhurst WH, CHun YS, Aloia TA, Vauthey JN, Tzeng CW. Right posterior sectionectomy and En Bloc diaphragm resection with intraoperative air leak test. Ann Surg Oncol (Video), 2019. PMID: None.
37. Vreeland TJ, Simoneau E, Westin S, Mehran R, Dewhurst WH, Chun YS, Aloia TA, Vauthey JN, Tzeng CW. Intraoperative air leak test to prevent bile leak after right posterior sectionectomy with en bloc diaphragm resection for metastatic teratoma. SSO 72 Annual Meeting, San Diego, CA, Oral Presentation, March 27-30, 2019, 2019. PMID: None.
38. Newhook TE, Arvide M, Vreeland TJ, Oiao W, Wang X, Velasco J, Chun YS, Aloia TA, Vauthey JN, Tzeng CD. Opioid prescribing patterns after hepatectomy: opportunities for minimizing variation and dissemination. Oral Presentation - AHPBA, Miami, FL, 03/24/2019, 2019. PMID: None.
39. Lee AJ, Hall C, Hurd M, Lucci A, Kim M, Lee JE, Katz M, Maitra A, Rhim A, Tzeng CW. Feasibility of intraoperative CTC detection from portal vein during resection for pancreatic adenocarcinoma. Oral Presentation - AHPBA, Miami, FL, 03/24/2019, 2019. PMID: None.
40. Newhook TE, Vreeland T, Dewhurst W, Arvide M, Bruno M, Robinson KA, Rajkot N, Lillemoe H, Grubb E, Aloia TA, Katz MHG, Vauthey JN, Lee JE, Tzeng CD. Variation in contemporary perioperative opioid prescribing practices in surgical oncolog. SSO 72 Annual Meeting, San Diego, CA, Oral Presentation, March 30, 2019, 2019. PMID: None.
41. Keung E, Asare E, Chiang YJ, Prakash LR, Rajkot N, Roland CL, Torres KE, Cormier J, Feig BW, Katz MHG, Lee JE, Tzeng CW. Postoperative pancreatic fistula and morbidity after distal pancreatectomy for non-pancreas retroperitoneal tumor resection. SSO 2019 Annual Meeting, San Diego, CA, Oral Presentation, March 27-30, 2019, 2019. PMID: None.
42. Newhook TE, Vega EA, Vreeland TJ, Prakash L, Dewhurst WL, Bruno M, Kim MP, Ikoma N, Vauthey JN, Katz MHG, Lee JE, Tzeng CD. Early postoperative drain fluid amylase in risk-stratified patients: implications for tailored post-pancreatectomy drain management. Oral Presentation - AHPBA, Miami, FL, 03/24/2019, 2019. PMID: None.
43. Lee A, Prakash L, Chiang Y, Kim M, Ikoma N, Aloia TA, Vauthey JN, Lee JE, Katz M, Tzeng CD. Pathologic nodal staging of resected pancreatic adenocarcinoma predicts survival regardless of treatment sequencing. SSO 72 Annual Meeting, San Diego, CA, Oral Presentation, March 27-30, 2019, 2019. PMID: None.
44. Vicente D, Lee AJ, Hall CS, Lucci A, Vreeland T, Newhook T, Lee JE, Kim MP, Katz MHG, Hurd M, Alvlarez H, Maitra A, Rhim AD, Tzeng CWD. Circulating tumor cells and transforming growth factor beta in pancreatic adenocarcinoma. Academic Surgical Congress (ASC), 2018. PMID: None.
45. Lee A, Simoneau E, Chiang Y, Lee JE, Kim M, Aloia TA, Vauthey JN, Katz MH, Tzeng CW. Is early-stage pancreatic adenocarcinoma truly early: stage migration on final pathology with surgery-first vs. neoadjuvant therapy sequencing. Society of Asian Academic Surgeons (SAAS), 2018. PMID: None.
46. Newhook T, Dewhurst W, Chen HC, Xuemei W, Kim M, Aloia TA, Vauthey JN, Lee JE, Katz MHG, Tzeng CW. Variation in and Predictors of Inpatient Opioid Utilization after Pancreatectomy. IHPBA 2018 - EP02D-107, 2018. PMID: None.
47. Dewhurst W, Newhook T, Chen HC, Xuemei W, Bruno M, Kim M, Vauthey JN, Lee JE, Katz MHG, Tzeng CW. Impact of First-day Intravenous Patient Controlled Analgesia Use on Total Inpatient Opioid Use after Pancreatectomy. IHPBA 2018 - EP02F-026, 2018. PMID: None.
48. Lee A, Chiang YJ, Chun YS, Conrad C, Kaseb A, Raghav K, Aloia TA, Vauthey JN, Tzeng CW. Selective Lymph Node Sampling in Resectable Hepatocellular Carcinoma: National Practice Patterns and Node Positivity Rates. IHPBA 2018 - FP20-02, 2018. PMID: None.
49. Simoneau E, Goumard C, Lee JE, Vauthey JN, Aloia TA, Chun YS, Conrad C, Kim M, Katz M, Tzeng CW. Improved Superior Mesenteric Artery Exposure and Reduced Blood Loss Risk Using Temporary Mesocaval Shunt for Locally Advanced Pancreatic Cancer. IHPBA 2018 - FP22-09, 2018. PMID: None.
50. Vauthey JN, Limani P, m J, Oodidio BC, Aloia TA, Chun YS, Tzeng CW. Obstructive Jaundice Algorithm - An Interdisciplinary Approach for the Management of Bile Duct Obstruction’. IHPBA 2018 - EPTT-039, 2018. PMID: None.
51. Zagzag J, Scally C, Dadu R, Tzeng CW, Perrier N. A 3-decade surprise. The American Association of Endocrine Surgeons (AAES):Mini Shot Format, 2018. PMID: None.
52. Lee AJ, Chiang Y, Conrad C, Chun YS, Lee J, Aloia T, Vauthey JN, Tzeng CW. National trends and predictors of adequate nodal sampling for resectable gallbladder adenocarcinoma. J Surg Res; Abstract ASC20181128, 2017. PMID: None.
53. Kim B, Day R, Tzeng CW, Aloia TA. Extended pharmacologic thromboprophylaxis in liver surgery is safe and effective. 2017 AHPBA Annual Meeting MO 117, 2017. PMID: None.
54. Cloyd J, Tzeng CW, Mizuno, Conrad C, Omichi K, Aloia TA, Vauthey JN, Chun YS. BRAF mutation is not a contraindication to resection of colorectal liver metastases. 2017 AHPBA Annual Meeting MO 37, 2017. PMID: None.
55. Kuttlu O, Tzeng CW, Fleming J, Varadhachary G, Javle M, Katz M, Vauthey JN, Lee JE, Conrad C. Low volume institutions are associated with delay and omission of adjuvant chemotherapy for resected pancreatic adenocarcinoma independent of surgical approach. 2017 AHPBA Annual Meeting MO 49, 2017. PMID: None.

Book Chapters

1. Tzeng CWD. Management of Resectable and Borderline Resectable Disease: Surgery. In: Pancreatic Cancer: A Multidiscliplinary Approach. 1. Springer Cham, 127-137, 2022.
2. Simoneau E, Aloia TA, Tzeng CWD. Enhanced Recovery after Liver Surgery. In: Colorectal Cancer Liver Metastases: A Comprehensive Guide to Management. None. Springer, 329-344, 2021.
3. Tzeng CW, Vauthey JN. Liver Anatomy, Physiology, and Preoperative Evaluation. In: Handbook of Hepatobiliary and Pancreatic Surgery. None. Lippincott, 111-125, 2014.
4. Abad JD, Tzeng CW, Vauthey JN. Extended Liver Resection Following Portal Vein Embolization. In: American College of Surgeons Multimedia Atlas:Liver Volume. None. Cine-Med, 419-426, 2014.
5. Cooper AB, Tzeng CW, Katz MHG. Surgical aspects of pancreatic cancer. In: Cancer Consult: Expertise for Clinical Practice. None. John Wiley & Sons, Ltd, 723-728, 2014.
6. Tzeng CW, Aloia TA. Complications of Liver Surgery Including Hepatic Insufficiency. In: Handbook of Hepatobiliary and Pancreatic Surgery. None. Lippincott, 221-232, 2014.
7. Tzeng CW, Howard JH, Bland KI. Mastectomy. In: Breast Surgical Techniques and Interdisciplinary Management. None. Springer, 409-422, 2011.
8. Howard JH, Tzeng CW, Fix RJ, Bland KI. Chest Wall Resection. In: Klimberg VS. Atlas of Breast Surgical Techniques: Surgical Techniques Atlas Series. None. Saunders Elsevier, 352-371, 2009.
9. Tzeng CWD, Prakash L. Borderline Resectable and Locally Advanced Pancreatic Cancer. In: Pancreatic Cancer - Current Therapeutics and Future Directions. None. Springer Nature Switzerland AG.

Letters to the Editor

1. Nishioka Y, Tzeng CWD, Tran Cao HS, Vauthey JN. COVID-19 outbreak and surgeons’ response at a Cancer Center in the United States. Global Health & Medicine. 2020; 2(2):135-137 2: 135-137, 2020.
2. Vega EA, Simoneau E, Tzeng CD, Odisio BC, Aloia TA, Chun YS, Vauthey JN. Letter to the Editor Regarding "ALPPS Improves Resectability Compared with Conventional Two-Stage Hepatectomy in Patients with Advanced Colorectal Liver Metastasis": When Innovation is Not Enough. Ann Surg 270: e35-e36.